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ABSTRACT
Skeletal muscle, which composes over 40% of body mass, is responsible for daily 
locomotion and energy metabolism. It is a malleable tissue that can adapt its structure and 
function in response to internal and external environmental stimuli. Changing muscle 
mass and energy substrate utilization is a common skeletal muscle adaptation in response 
to various pathological conditions, including type 2 diabetes and obesity. Failure to 
maintain skeletal muscle mass and function has been correlated with increasing morbidity 
and mortality, as well as poor quality of life. Hence, maintenance of skeletal muscle 
integrity is a recommended strategy in achieving better quality of life. TRB3 is a 
pseudokinase that is known to negatively regulate Akt phosphorylation, a key protein 
kinase in regulating protein turnover and energy metabolism in skeletal muscle. Although 
TRB3 is found in skeletal muscle and its expression is associated with Akt signaling, no 
previous studies have elucidated the effects of TRB3 on skeletal muscle mass regulation. 
The purpose of this dissertation was to determine the role of TRB3 in skeletal muscle 
mass regulation and exercise-induced adaptation. We hypothesized that TRB3 expression 
would regulate protein turnover by regulating Akt and its downstream proteins, mTOR 
and FOXO, at the basal state and under atrophic conditions. We also expected TRB3 
expression to blunt exercise-induced skeletal muscle adaptation. In Aim 1, we tested 
whether TRB3 expression in mouse skeletal muscle regulated protein turnover through 
the Akt/mTOR/FOXO pathway at the basal state. We found that skeletal muscle protein 
turnover was regulated by TRB3 expression. In Aim 2, we examined whether TRB3 
expression in mouse skeletal muscle affected food deprivation (FD)-induced skeletal 
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muscle atrophy. We observed that muscle-specific TRB3 overexpression worsened FD-
induced atrophy via increasing proteolysis systems, while TRB3 knockout prevented the 
atrophy by preserving protein synthesis. In Aim 3, we tested whether TRB3 expression 
was involved in exercise-induced skeletal muscle adaptation. Here, we found that muscle 
specific TRB3 overexpression blunted the benefits of exercise training in glucose uptake 
and mitochondrial adaptation. These findings provide evidence that TRB3 is a potential 
target to improve skeletal muscle integrity and quality in both healthy conditions and 
atrophic conditions.  
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CHAPTER 1 
INTRODUCTION
    2
Skeletal muscle is a highly malleable tissue that responds to internal and external 
environmental stimuli. It is able to alter muscle fiber size, function, and metabolism 
depending on whether the stimuli are anabolic or catabolic. Moreover, skeletal muscle 
supports daily locomotion, force generation, and energy storage, which are essentials for 
daily life. However, pathological stimuli can disrupt the regulation of skeletal muscle 
integrity, resulting in loss of muscle mass and mechanical and metabolic function. The 
loss of skeletal muscle mass, also known as muscle atrophy or wasting, is a common 
phenomenon caused by physical inactivity; fasting; aging and several diseases, including 
cancer, diabetes, and heart failure. Muscle atrophy is also associated with high morbidity 
and mortality, and poor quality of life. Therefore, the maintenance of skeletal muscle 
mass has been perceived as a critical component in pursuing a better quality of life. 
Although researchers have made efforts to prevent or delay skeletal muscle atrophy, they 
have not fully uncovered the molecular mechanism(s) involved in the progress of the 
disease. Hence, there is a critical need to develop new and more effective treatments for 
muscle atrophy.  
 
Skeletal muscle mass is determined by the balance between protein synthesis and 
degradation. When the rate of protein synthesis exceeds the rate of protein breakdown, it 
causes an increase in muscle mass and fiber size, known as muscle hypertrophy. By 
contrast, if the overall rate of protein degradation surpasses protein synthesis, it induces 
muscle atrophy, leading to a decrease in muscle mass and fiber size (Schiaffino, Dyar, 
Ciciliot, Blaauw, & Sandri, 2013). Anabolic stimuli, such as insulin, insulin-like growth 
factor-1 (IGF-1), and other growth factors, are required to increase or preserve skeletal 
muscle mass. These stimuli activate phosphatidylinositol 3-kinase (PI3K) and Akt, which 
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are considered as pivotal signaling molecules in regulating protein balance. For example, 
IGF-1 binds to its receptor and phosphorylates insulin receptor substrates (IRS) to recruit 
and activate PI3K, leading to subsequent phosphorylation and activation of Akt (Glass, 
2005). Akt is a chief regulator of protein synthesis and degradation because its activation 
can phosphorylate the mechanistic target of rapamycin (mTOR) for the activation of 
protein synthesis via the regulation of ribosomal S6 kinase 1 (S6K1) and eukaryotic 
translation initiation factor 4E-binding protein 1 (4EBP1), while it can inhibit the 
translocation of forkhead box O transcription factors (FOXOs) into the nucleus to 
inactivate protein degradation. Research has demonstrated that constitutively active Akt 
in C2C12 cells and in mouse tibialis anterior muscle is sufficient to increase muscle in 
cross-sectional area and fiber size (Bodine, Stitt, et al., 2001; Rommel et al., 2001). Akt-
induced hypertrophy is attenuated by treatment with rapamycin, an mTOR inhibitor, 
suggesting the Akt/mTOR pathway is necessary for muscle hypertrophy (Bodine, Stitt, et 
al., 2001; Rommel et al., 2001). In addition, IGF-1 treatment in dexamethasone-treated 
C2C12 myotubes prevents dexamethasone-induced myotube atrophy by phosphorylating 
Akt and FOXOs, resulting in decreased skeletal muscle-specific E3 ubiquitin ligases, 
atrogin-1 and muscle RING finger-1 (MuRF-1) expression (Sandri et al., 2004; Stitt et 
al., 2004). This effect has been further demonstrated under in vivo atrophic conditions, 
using glucocorticoids and denervation, that increasing Akt phosphorylation by IGF-1 
supplement significantly blunts skeletal muscle atrophy associated with increasing the 
phosphorylation of FOXOs and reducing the expression of atrogenes (Stitt et al., 2004). 
Taken together, the IGF-1/PI3K/Akt pathway is a central mechanism in regulating 
skeletal muscle mass in basal and atrophic conditions. However, it has not been fully 
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understood what mechanism(s) manage Akt activity to create a balance between 
protein synthesis and degradation.  
 
Tribbles homolog 3 (TRB3) is a mammalian homolog of Drosophila Tribbles. It 
is a pseudokinase, meaning it contains a kinase-like domain without an ATP-binding site 
or catalytic activity (Grosshans & Wieschaus, 2000; Hegedus, Czibula, & Kiss-Toth, 
2006). Research has shown that, due to its lack of catalytic activity, TRB3 acts like a 
scaffold or a mediator protein by binding to target proteins to control their functions 
(Boudeau, Miranda-Saavedra, Barton, & Alessi, 2006). TRB3 is known as a negative 
regulator of Akt because it disrupts the phosphorylation in liver and skeletal muscle (Du, 
Herzig, Kulkarni, & Montminy, 2003; Koh et al., 2013; J. Liu et al., 2010). Studies have 
demonstrated that in the liver, hepatic TRB3 expression increases under stressful 
conditions, including fasting and insulin resistance; and that it inhibits Akt 
phosphorylation at both T308 and S473 phosphorylation sites (Du et al., 2003). The liver 
of a mouse with overexpressed TRB3 displays impaired glucose tolerance, increased 
hepatic glucose output, and reduced glycogen content in comparison with the liver of a 
control mouse (Du et al., 2003).  Previous studies have reported that higher TRB3 
expression is found in muscle samples from obese and type 2 diabetic patients than in 
samples from healthy controls (Koh et al., 2013; J. Liu et al., 2010). High expression of 
TRB3 is positively correlated with fasting blood glucose and is inversely related to 
glucose disposal rate (J. Liu et al., 2010). Moreover, endoplasmic reticulum (ER) stress-
induced insulin resistance in mouse skeletal muscle relates to increasing TRB3 
expression (Koh et al., 2013). TRB3 knockdown via RNA interference (RNAi) in C2C12 
myotubes ameliorates the impairment of insulin-stimulated phosphorylation of IRS-1 and 
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Akt under ER stress conditions (Koh et al., 2013). In addition, TRB3 knockout mice do 
not show high-fat diet-induced weight gain, but do show improved glucose tolerance and 
enhanced insulin-stimulated phosphorylation of IRS-1 and Akt when compared to wild 
type mice (Koh et al., 2013). These data suggest that TRB3 expression is associated with 
impaired insulin signaling under stressful conditions such as obesity, diabetes, and ER 
stress. However, it has not been fully understood whether TRB3 plays a role in skeletal 
muscle mass regulation mediated by the IGF-1/PI3K/Akt pathway. Given the function 
of TRB3 in the regulation of Akt activity under metabolically stressful conditions, 
TRB3 would be a potent candidate for coordinating protein turnover in skeletal 
muscle by managing Akt and its downstream proteins. Currently, little is known 
about the roles of TRB3 in skeletal muscle, especially in muscle mass regulation. 
Therefore, it is important to investigate whether TRB3 is a key molecule in 
mediating protein synthesis and breakdown in basal and atrophic conditions.  
 
Increasing physical activity is another strategy for retaining skeletal muscle 
integrity in order to produce better outcomes following metabolic deterioration and 
chronic disease. It is well-established that exercise not only improves metabolic 
conditions, such as glycemic control, whole-body glucose, and fat metabolism, but also 
maintains the integrity of skeletal muscle, including its mass and function, resulting in 
better quality of life (Egan & Zierath, 2013). Metabolic benefits of regular physical 
activity on skeletal muscle include elevated enzyme activity involved in glucose and fat 
metabolism, as well as enhanced glucose uptake and insulin sensitivity (Egan & Zierath, 
2013). These allow skeletal muscle to produce and utilize energy sources more 
efficiently. It has been found that short- and long-term use of moderate endurance 
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exercise increases the expression and translocation of glucose transporter 4 (GLUT4) 
(Goodyear et al., 1990; Ploug et al., 1990), glucose uptake (Dela, Mikines, von Linstow, 
Secher, & Galbo, 2006; Richter, Mikines, Galbo, & Kiens, 1989), and the expression of 
hexokinase II (Jorgensen, Jensen, & Richter, 2007; O'Doherty, Bracy, Osawa, 
Wasserman, & Granner, 1994) in rodent and human skeletal muscle. Moreover, skeletal 
muscle fibers are directly influenced by aerobic exercise, resulting in an alteration of 
specific contractile proteins, such as myosin heavy chain isoforms, and an increase in 
oxidative capacity (Gollnick et al., 1973; J. O. Holloszy & Booth, 1976; Rockl et al., 
2007). Overall, these exercise-induced alterations in skeletal muscle contribute to 
improved glucose metabolism, insulin sensitivity, and oxidative capacity.  
 
Elevated TRB3 expression has been found in obese and diabetic in mice and in 
humans (Koh et al., 2013; J. Liu et al., 2010).Previous studies have also shown that 
TRB3 is responsive to exercise training in obese and diabetic rodent models.  Acute 2 h-
swimming exercise in ob/ob mice improves insulin-simulated IRS-1 and Akt signaling 
with decreased TRB3 expression in skeletal muscle (Matos et al., 2010). Exercise also 
diminishes TRB3/Akt association in exercised skeletal muscle from ob/ob mice 
compared to sedentary groups (Matos et al., 2010). Another recently published study has 
demonstrated that TRB3 expression may assist exercise capacity in mouse models. 
Muscle-specific TRB3 transgenic mice have displayed a greater time to exhaustion 
exercise capacity and a higher portion of oxidative muscle fiber types in soleus and 
tibialis anterior muscles (An et al., 2014). Although the role of TRB3 in the regulation 
of the PI3K/Akt pathway has been demonstrated, little is known about the effects of 
TRB3 in overall exercise-induced metabolic and skeletal muscle adaptations.  
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Overall premise 
Skeletal muscle is a highly plastic tissue, meaning that it can adjust its function 
and formation depending on internal and external stimuli. Chronic diseases, which need 
long-term care and cost tremendous amounts in health-related billing, often arouse 
skeletal muscle wasting and impair skeletal muscle function, thus leading to high 
mortality and poor quality of life. Therefore, preserving skeletal muscle integrity is an 
essential approach to enhancing quality of life among patients with pathologic conditions. 
To preserve better muscle quality, maintaining skeletal muscle mass via nourishing diet 
and regular physical activity is critical. However, current knowledge is limited regarding 
the protection of muscle quality under catabolic conditions. The IGF-1/PI3K/Akt 
pathway has been explored as a major molecular mechanism in regulating skeletal muscle 
mass. The activity of Akt controls protein synthesis and breakdown through the 
regulation of mTOR and FOXOs activation. Although the significance of Akt signaling is 
well known, it has not been completely elucidated the manner in which molecule(s) 
switch Akt signaling on and off to regulate the balance of protein synthesis and 
degradation. TRB3 has been known as a negative regulator of Akt in multiple tissues, 
including skeletal muscle. Its function in skeletal muscle has been limited with regard to 
insulin resistance and glucose homeostasis. However, with regard to maintaining skeletal 
muscle integrity through mass regulation and exercise-mediated adaptation, TRB3 has 
great potential to be a direct regulator of the Akt signaling process which manages 
protein balance.  
 
 
 
    8
Overall purpose and hypothesis 
The overall purpose of this study is to determine the roles of TRB3 in muscle 
mass regulation and exercise-induced adaptation in mouse skeletal muscle. The central 
hypothesis is that TRB3 expression will decrease protein synthesis and increase 
degradation by regulating Akt signaling at basal state and under atrophic conditions. In 
addition, TRB3 will play a pivotal role in exercise-induced skeletal muscle adaptation 
with respect to glucose metabolism and oxidative capacity. In order to test this 
hypothesis, we will determine whether TRB3 regulates skeletal muscle mass through 
regulation of Akt and its downstream proteins at basal state. Next, we will examine the 
effects of TRB3 on skeletal muscle mass under atrophic conditions. Lastly, we will 
determine whether TRB3 plays a significant role in exercise-induced skeletal muscle 
adaptation. We will utilize muscle-specific TRB3 transgenic and whole-body TRB3 
knockout mice models to determine the roles of TRB3 in skeletal muscle mass regulation 
and exercise adaptation. Atrophy will be induced by fasting, a method which is well 
established and confirmed by other researchers (Garlick, Millward, James, & Waterlow, 
1975; Gomes, Lecker, Jagoe, Navon, & Goldberg, 2001; Lecker et al., 2004; Li & 
Goldberg, 1976). Exercise training will be induced via two different procedures, 
voluntary wheel cage and forced treadmill training.  
 
Specific aims 
To investigate proposed hypotheses, we set three specific aims, including sub-
aims: 
Specific Aim 1: To determine whether TRB3 regulates skeletal muscle mass through 
Akt and its downstream proteins, mTOR and FOXOs at the basal state 
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Aim 1.1: To determine whether muscle-specific TRB3 overexpression disrupts Akt and 
its downstream signaling proteins 
Aim 1.2: To determine whether global deletion of TRB3 benefits skeletal muscle mass 
and function through the Akt signaling pathway 
 
Specific Aim 2: To examine the role of TRB3 in skeletal muscle mass regulation 
under atrophic conditions  
Aim 2.1: To test whether fasting-induced ER stress regulates TRB3 expression in C2C12 
mouse myoblasts 
Aim 2.2: To determine whether muscle-specific TRB3 overexpression aggravates fasting-
induced atrophy  
Aim 2.3: To determine whether the knockout of TRB3 ameliorates fasting-induced 
atrophy  
 
Specific Aim 3: To examine whether TRB3 affects exercise-induced skeletal muscle 
adaptation  
Aim 3.1: To determine whether muscle-specific TRB3 overexpression disrupts exercise-
induced skeletal muscle adaptation through inactivation of Akt and its downstream 
proteins 
Aim 3.2: To determine whether TRB3 is required for exercise-induced metabolic and 
morphological skeletal muscle adaptation 
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Proposed working model 
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Figure 1.1 Overall working model for proposed aims. The overall purpose of the 
current study is to determine the roles of TRB3 in skeletal muscle in terms of mass 
regulation and exercise-induced adaptation. Our central hypothesis is that increasing 
TRB3 expression in mouse skeletal muscle will interfere with Akt and its downstream 
signaling pathways, including mTOR and FOXOs, to disrupt the balance between protein 
synthesis and degradation at basal state and under atrophic conditions. Specific aim 1 will 
investigate the effects of TRB3 in skeletal muscle mass regulation at basal state, using 
muscle-specific TRB3 overexpressed and whole-body TRB3 knockout mouse models. 
Specific aim 2 will examine the roles of TRB3 in fasting-induced skeletal muscle atrophy 
with our mouse models. In addition, we will directly examine an upstream mechanism to 
induce TRB3 expression under fasting-induced atrophy conditions in C2C12 mouse 
myoblasts. Specific aim 3 will determine the roles of TRB3 in exercise-induced skeletal 
muscle adaptation with regard to glucose metabolism and oxidative capacity. 
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CHAPTER 2 
LITERATURE REVIEW
 13 
2.1 Tribbles homolog 3 (TRB3) 
Discovery of tribbles protein  
A mammalian homolog of Drosophila tribbles was first discovered in Drosophila 
melanogaster, and as a protein it is highly conserved from Drosophila to humans (Mata, 
Curado, Ephrussi, & Rorth, 2000; Seher & Leptin, 2000). The tribbles protein inhibits 
mitosis by arresting the cell cycle in the G2 phase and degrading two Drosophila cell 
cycle regulators, string and twine (homologs of mammalian cyclin-dependent kinase 25) 
via proteasomal breakdown (Mata et al., 2000). Moreover, the tribbles protein has been 
reported to alter the ubiquitin-proteasome in a way that degrades slow border cells, the 
mammalian homolog of CCAAT-enhancer binding proteins (C/EBPs) (Masoner et al., 
2013; Rorth, Szabo, & Texido, 2000). In mammals, there are three isoforms of the 
tribbles homolog protein, including TRB1, TRB2, and TRB3. All these isoforms contain 
a conserved protein kinase domain lacking kinase capacity, called a pseudokinase, and 
have similar functional domains. Although they share analogous domains, each isoform 
is expressed in different tissues and shows distinct roles in various cellular processes. 
First, TRB1 is preferentially found in the nucleus which has been shown to increase 
metabolic dysfunction in vascular tissues and to regulate Akt in retinoic acid receptor and 
endothelial cells (Ashton-Chess et al., 2008; Imajo & Nishida, 2010; Mondal, Mathur, & 
Chandra, 2016). In smooth muscle cells, TRB1 overexpression mediates the mitogen-
activated protein kinase pathway (Sung et al., 2007). Recently, studies have shown that 
M2 macrophage differentiation is affected by TRB1 expression, suggesting an 
association with inflammation (Y. H. Liu, Tan, Morrison, Lamb, & Argyle, 2013). 
Research has connected TRB2 to tumorigenesis in acute myelogenous leukemia, 
melanoma, and hepatocellular carcinoma (Keeshan et al., 2006; Keeshan, Shestova, 
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Ussin, & Pear, 2008; J. Wang et al., 2013; Zanella et al., 2010). Meanwhile, TRB3 has 
been found in both nucleus and cytoplasm, and is globally associated with several 
different diseases, including type 2 diabetes (T2DM), cardiovascular disease, obesity, and 
cancer (Avery et al., 2010; Hua et al., 2015; Oberkofler et al., 2010; Ti et al., 2011). In 
addition, studies have revealed that TRB3 regulates stress-related metabolic responses, 
such as glucose and lipid metabolism, apoptosis, tumorigenesis, and endoplasmic 
reticulum (ER) stress (Koh et al., 2013; J. Liu et al., 2010; Ord & Ord, 2003, 2005; 
Saleem & Biswas, 2017; Schwarzer, Dames, Tondera, Klippel, & Kaufmann, 2006; 
Yacoub Wasef, Robinson, Berkaw, & Buse, 2006).  
 
Functions of TRB3 
TRB3 is the most-studied isoform among tribbles homolog proteins because it is 
ubiquitously expressed in multiple tissues, including liver, pancreas, adipose tissue, 
kidney, and skeletal muscle. Also, TRB3 is known to be a cellular stress-responsible gene 
in various conditions such as fasting (Du et al., 2003; Koo et al., 2004), cancer (Bowers, 
Scully, & Boylan, 2003; Xu et al., 2007), T2DM (J. Liu et al., 2010; Zhang et al., 2016), 
obesity (Koh et al., 2013; Marinho et al., 2012), and ER stress (Koh et al., 2013; Ord & 
Ord, 2005). It  has been shown that, to maintain cellular homeostasis in response to these 
stresses, TRB3 is involved in several cellular processes, including insulin signaling (Du 
et al., 2003; Koh et al., 2006; Koh et al., 2013; J. Liu et al., 2010), glucose and lipid 
metabolism (Bi et al., 2008; Qi et al., 2006), autophagy (Salazar et al., 2009; Saleem & 
Biswas, 2017), and cell differentiation (Kato & Du, 2007). Research has continuously 
discovered the functions of TRB3 and it premise to be a potential target to ameliorate the 
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consequences of various cellular stress circumstances. Therefore, it is important to 
discuss what is currently known and how to determine further roles of TRB3. 
 
TRB3 and Insulin signaling 
TRB3 is well known as a negative regulator of Akt which works by interfering 
with the phosphorylation sites Thr308 and Ser473, which are responsible for a critical 
insulin signaling pathway (Du et al., 2003). Several studies have demonstrated that 
insulin resistance condition in rodents and humans leads to an increase in TRB3 
expression, and that this is associated with an impairment of insulin signaling, especially 
the inhibition of Akt phosphorylation (Fischer et al., 2017; Prudente & Trischitta, 2015). 
A number of in vitro and in vivo studies have already demonstrated that TRB3 plays a 
pivotal role in Akt activation and is associated with insulin signaling pathways. In 
cultured cell studies, it has been reported that high-fat conditional media incubation, 
including palmitic acids, on HepG2 hepatocytes, human umbilical vein endothelial cells, 
and C2C12 myoblasts, increases TRB3 expression and decreases insulin-stimulated 
phosphorylation of Akt (Geng et al., 2013; Koh et al., 2013; Liang et al., 2015). 
Moreover, knockdown of TRB3 expression in HepG2 hepatocytes by RNAi increases 
Akt phosphorylation at Ser473, resulting in the deactivation of glycogen synthase kinase 
3 (GSK3) and FOXO1 (Du et al., 2003). Another study confirms these findings in the 
same HepG2 cells transfected by small interfering RNA (siRNA) against TRB3, and 
further demonstrates that inhibition of TRB3 expression increases the phosphorylation of 
S6K1 and 4E-BP1, which are downstream proteins of the Akt signaling pathway 
(Matsushima, Harada, Webster, Tsutsumi, & Nakaya, 2006). On the other hand, 
adenoviral injection-induced TRB3 overexpression in primary mouse hepatocytes 
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reverses these results, diminishing the levels of phosphorylated S6K1 and 4E-BP1 and 
suggesting that Akt activation would be impaired (Matsushima et al., 2006). In C2C12 
myoblasts, the overexpression of TRB3 has been shown to decrease insulin-stimulated 
Akt and IRS1 phosphorylation (Koh et al., 2006; Koh et al., 2013). In addition, the cells 
treated with ER stress inducers, including tunicamycin and thapsigargin, greatly increase 
TRB3 expression and decrease the activation of insulin-stimulated IRS1 and Akt. 
However, deletion of TRB3 by RNAi in tunicamycin-treated C2C12 myoblasts recovers 
insulin-stimulated phosphorylation of IRS1 and Akt (Koh et al., 2013). Overexpression of 
TRB3 in rat L6 skeletal muscle cells also significantly reduces the phosphorylation of 
Akt and extracellular signal-regulated kinases 1 and 2 with suppressed GLUT4 
translocation after insulin stimulation (J. Liu et al., 2010). In in vivo studies, TRB3 
expression has been demonstrated to play a significant role in insulin signaling pathways. 
Recently, it has been reported that higher TRB3 expression is found in the skeletal 
muscle of obese and diabetic populations than in the skeletal muscle of healthy, normal-
weight people (Koh et al., 2013; J. Liu et al., 2010). Consistent with the findings in obese 
and diabetic human subjects, elevated TRB3 expression is evident in various 
metabolically dysfunctional animal models, including db/db (lack of leptin receptor) and 
ob/ob (lack of leptin hormone) mice, Zucker fatty rats, and diet-induced obesity rodent 
models (Du et al., 2003; Koh et al., 2013; Lima et al., 2009; J. Liu et al., 2010; Marinho 
et al., 2012; Sun et al., 2017). Subsequently, these models have demonstrated that obese 
and diabetic pathophysiological conditions induce TRB3 expression and also impair 
insulin-stimulated Akt activation (Koh et al., 2013; Lima et al., 2009; J. Liu et al., 2010; 
Marinho et al., 2012). In addition, hepatic TRB3 overexpression via adenoviral tail vein 
injection disrupts glucose tolerance and gluconeogenesis in test mice as compared to 
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control mice (Du et al., 2003). Although TRB3 overexpression in rodent models could be 
responsible for insulin insensitivity, the knockout of TRB3 in mice has not demonstrated 
a clear effect on insulin signaling. First, a study knocking out TRB3 in the mouse showed 
no change in insulin-stimulated Akt activation and other downstream proteins, glucose 
tolerance, and insulin sensitivity (Okamoto et al., 2007). However, whole-body TRB3 
knockout (KO) mice prevent diet-induced obesity over the course of 8 weeks of high-fat 
feeding. And these KO mice has shown improved insulin signaling demonstrated by 
increasing insulin-stimulated phosphorylation of IRS1, Akt, and FOXO (Koh et al., 
2013). It should be noted that in this study, liver weight and triglyceride contents after 8 
weeks of high-fat diet were also decreased in KO (Koh et al., 2013). In summary, several 
in vivo and in vitro studies have demonstrated that TRB3 is an important regulator of the 
insulin signaling pathway through Akt under metabolically abnormal conditions.  
 
TRB3 and Metabolism 
Since TRB3 is known as a negative regulator of Akt phosphorylation, the primary 
focus in determining its roles has been Akt-related insulin signaling, including glucose 
metabolism and insulin resistance. The relationships between these topics and roles of 
TRB3 have been demonstrated in multiple tissues, including liver, heart, fat, and skeletal 
muscle, using diverse animal models and cell cultured studies. In the liver, an organ 
essential in controlling whole-body glucose and lipid metabolism, mice overexpressing 
TRB3 via adenoviral tail vein injection present impaired glucose tolerance and glucose 
output – which suggests developed insulin insensitivity. Meanwhile, knocking down 
TRB3 in FAO hepatocytes decreases insulin-response glucose output and increases 
glycogen synthesis, as confirmed by the inhibition of insulin-stimulated GSK3b (Du et 
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al., 2003). In line with results showing that TRB3 overexpression disrupts glucose 
metabolism, another study using a tail vein injection of TRB3 expressed adenovirus to 
C57BL/6 mice supports the hypothesis that TRB3 overexpression in the liver debilitates 
glucose and insulin tolerance without changing the body weight or serum insulin level 
(Matsushima et al., 2006). On the other hand, in adipose tissue, a chief area responsible 
for the lipid metabolism which supplies energy for the demands of daily life, fat-specific 
TRB3 transgenic mice demonstrate increased fatty acid oxidation, which prevents diet-
induced obesity (Qi et al., 2006). This study has further determined that fat-specific 
TRB3 transgenic mice show little or no body weight gain after 5 weeks of high-fat diet 
when compared to wild type, and they also show decreased white adipose tissue mass 
after high-fat diet feeding (Qi et al., 2006). Furthermore, studies have shown that TRB3 
can be associated with E3 ubiquitin ligase, called COP1, in adipocytes to degrade acetyl-
coenzyme A carboxylase, which is a rate limiting enzyme of fatty acid synthesis, in order 
to inhibit lipogenesis (Qi et al., 2006).  In the heart, cardiac-specific TRB3 
overexpression in mice decreases glucose oxidation rates (though not fatty acid 
oxidation) (Avery et al., 2010). In accordance with the role of TRB3 in glucose 
metabolism and insulin signaling in liver and heart, a number of studies have reported 
that TRB3 expression plays a significant role in metabolism in skeletal muscle as well. 
Earlier studies (using human subjects and genetically modified animal models, including 
db/db and ob/ob mice and Zucker fatty rats) have proven that the expression of TRB3 in 
skeletal muscle is associated with metabolic dysfunctions such as diabetes and 
obesity(Koh et al., 2013; J. Liu et al., 2010). Other animal models with deleted liver 
kinase B 1 in skeletal muscle show improved glucose tolerance, resulting from a decrease 
in TRB3 expression in skeletal muscle (Koh et al., 2006). In addition, TRB3 
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overexpression in rat L6 myoblasts tagged with GLUT4myc decreases insulin-stimulated 
2-deoxy-D-glucose uptake and GLUT4 translocation (J. Liu et al., 2010). Furthermore, 
research has demonstrated a relationship between TRB3 and ER stress-induced insulin 
resistance (Koh et al., 2013). Treatments of tunicamycin and thapsigargin, ER stress 
inducers, induce TRB3 expression and result in a reduction of glucose uptake in mouse 
C2C12 myoblasts and skeletal muscle (Koh et al., 2013). However, TRB3 knockout mice 
treated with tunicamycin blunt the reduction of insulin-stimulated glucose uptake and 
resist high-fat diet-induced obesity, showing improved glucose tolerance and increased 
insulin-stimulated glucose uptake in soleus muscle compared to wild type (Koh et al., 
2013). Also, TRB3 expression in skeletal muscle is induced by glucose-induced insulin 
resistance or glucose toxicity. It is associated with increase in O-linked glycosylation, 
which is already linked to insulin resistance (Zhang et al., 2013; Zhang et al., 2016). 
Zhang et al. (2013) reported that glucose toxicity, induced by high (>25 mmol/L) and low 
(0 mmol/L) glucose, dramatically elevates TRB3 expression in rat L6 myoblasts, along 
with increasing O-linked glycosylation (Zhang et al., 2013). Recently, they created 
muscle-specific TRB3 overexpressed mice (using human TRB3 cDNA) and knockout 
mice (using the flippase recombinase target flanked-sequence in TRB3) to determine 
whether TRB3 mediates glucose toxicity in skeletal muscle (Zhang et al., 2016). Muscle-
specific TRB3 overexpression in mice impairs glucose tolerance and phosphorylation of 
insulin-stimulated Akt, Akt substrate 160kD, and glucose synthase after 6 weeks of 
diabetic condition induced by 5 days of streptozotocin injections (Zhang et al., 2016).  
High-fat diet feeding of these mice significantly increases body weight and fasting blood 
glucose compared to wild type, and mice with muscle-specific TRB3 overexpression 
shows highly increased pro-inflammatory markers, including NF-κB and TNF-α; and 
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activated stress-responsible markers, such as activating transcription factor 4 (ATF4) and 
CCAAT/enhancer-binding protein homologous protein (CHOP). However, muscle-
specific TRB3 knockout in mice abolishes these negative effects of hyperglycemia and 
diet-induced obesity (Zhang et al., 2016).  
 
TRB3 and ER stress 
As stated above, TRB3 is a gene responsible for stress, particularly ER stress 
(Jousse et al., 2007; Koh et al., 2013; Ohoka, Yoshii, Hattori, Onozaki, & Hayashi, 2005; 
Ord & Ord, 2003, 2005). Cellular stresses, like nutrient excess or deprivation, can disrupt 
homeostasis.  This increases the protein synthesis load to ER in order to coordinate 
metabolic alteration and cellular transformation, resulting in an increase in unfolded 
protein response (UPR). UPR is a regulatory response to cellular stress; however, it can 
also initiate stress-signaling pathways that attenuate stress-adaptive reactions and 
promote uncontrolled UPR in ER. These phenomena, called ER stress, can hinder cell 
survival mechanisms and facilitate cell death, resulting in metabolic diseases and cancer 
(Dicks, Gutierrez, Michalak, Bordignon, & Agellon, 2015; Guerrero-Hernandez, Leon-
Aparicio, Chavez-Reyes, Olivares-Reyes, & DeJesus, 2014; S. Wang & Kaufman, 2012). 
Excessive UPR responses can induce ER stress responses by activating three different 
arms: activating transcription factor 6 (ATF6), inositol requiring enzyme 1 pathway 
(IRE1), and double-stranded RNA-activated protein kinase-like ER kinase (PERK) 
pathway (Walter & Ron, 2011). It has been demonstrated that TRB3 is particularly 
associated with the PERK pathway that exerts ER stress-mediated responses through the 
phosphorylation of eukaryotic translation initiation factor 2 alpha (eIF2α), leading to an 
arrest of global translation (Bromati et al., 2011; Fang et al., 2014; Ohoka et al., 2005; 
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Qian et al., 2008). Although this process reduces the burden of protein folding load to the 
ER lumen, phosphorylated eIF2α increases ATF4 translation, which can regulate many 
genes related to metabolism and amino acid transport in response to oxidative stress 
(Harding et al., 2000). In addition, CHOP, a transcription factor, is activated by ATF4 
and induces encoding of genes involved in apoptosis (Sok et al., 1999; X. Z. Wang et al., 
1998; Zinszner et al., 1998). Therefore, the activation of the PERK arm is considered a 
powerful protective mechanism of ER stress-induced UPR responses.  
A number of reports describe TRB3 as a regulatory protein for ATF4 and CHOP 
(Corcoran et al., 2005; Jousse et al., 2007; Ohoka et al., 2005; Ord & Ord, 2003, 2005). 
ER stress induced by treatment with tunicamycin or thapsigargin can induce TRB3 
mRNA and protein expression in several in vitro settings, such as HepG2, C2C12, GT1-7 
cells (Koh et al., 2013; Ohoka et al., 2005; Ord & Ord, 2003, 2005). Increased TRB3 
expression by an ER stress inducer follows elevation of ATF4 and CHOP (Ohoka et al., 
2005; Ord & Ord, 2003). Moreover, it has been demonstrated that overexpression of 
ATF4 and/or CHOP can induce TRB3 promoter activity, whereas the deletion of 
ATF4/CHOP by siRNA decreases ER stress-induced TRB3 promoter activity (Ohoka et 
al., 2005). Interestingly, TRB3 co-expression with either ATF4 or CHOP overexpression 
inhibits its own expression, suggesting that TRB3 regulates its expression by suppressing 
ATF4 and CHOP in a negative feedback loop (Jousse et al., 2007; Ohoka et al., 2005). In 
addition, another study has reported that ATF4 and TRB3 co-expression in HEK293 cells 
suppresses ATF4-induced apoptosis, indicating that TRB3 plays an inhibitory role in 
ATF4 transcriptional activity (Ord, Meerits, & Ord, 2007). Nutrient deprivation 
conditions, such as leucine deprivation, induce TRB3 expression as well. The increment 
of TRB3 is shown to be associated with stress-induced ATF4 activation and to regulate 
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ATF4-related transcription activity (Jousse et al., 2007). Furthermore, overexpression or 
inhibition of TRB3 regulates CHOP promoter activity by leucine starvation, confirming 
the negative feedback loop between ATF4/CHOP and TRB3 (Jousse et al., 2007). Given 
the findings regarding the interaction of TRB3 with ATF4 and CHOP, ER stress shows 
potential as a regulator of TRB3 in stress conditions.  
 
TRB3 and Exercise  
Regular exercise is important not only in maintaining general health but also in 
preventing many diseases, including cardiovascular disease, obesity, and diabetes (Arena 
et al., 2017; Katzmarzyk, Lee, Martin, & Blair, 2017). Exercise also provides numerous 
beneficial effects on skeletal muscle with regard to insulin sensitivity in animals and 
humans. However, the question of whether insulin sensitivity in skeletal muscle can be 
restored by physical activity remains unanswered.  
Uncontrolled hepatic glucose production by insulin stimulation is an essential 
indicator of whole-body insulin insensitivity, but exercise has been shown to suppress the 
process, and to improve insulin signaling and tolerance (De Souza et al., 2010). Since the 
liver is the main organ that expresses TRB3 (Du et al., 2003; Koo et al., 2004; Ord & Ord, 
2005), previous research has focused on the effects of TRB3 in the liver on the regulation 
of hepatic insulin signaling with physical activity. One study, which applied acute 
swimming exercises (four sets of 30-minute swimming sessions with 5-minute rest 
periods for a total duration of 2 hours of exercise) to high-fat diet induced obesity mice 
and to ob/ob mice, demonstrates that hepatic TRB3 expression is significantly reduced 
after insulin stimulation; however, the level of TRB3 binding to Akt decreases 
dramatically in both exercise groups (Lima et al., 2009). Consequently, exercised obese 
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groups increase insulin sensitivity and glycogen content while they decrease 
gluconeogenesis proteins, such as phosphoenolpyruvate carboxylkinase (PEPCK), 
through FOXO1 inactivation compared to obese groups (Lima et al., 2009). Furthermore, 
another research group has reported that exercise-reduced TRB3 expression is due to an 
increased expression of endosomal adaptor protein (APPL1) (Marinho et al., 2012). 
APPL1 is an adaptor protein known to regulate Akt activity via direct binding, and 
research has shown that this protein competes with TRB3 in order to bind to Akt (Cheng 
et al., 2009; Hosch, Olefsky, & Kim, 2006). Endurance training using 60minute 
swimming protocol (5 days/week for 8 weeks) significantly decreases hepatic TRB3 
expression in high-fat diet-induced obese mice when compared to lean mice; this 
reduction is accompanied by an increase in APPL1. Elevated hepatic APPL1 has been 
shown to increase Akt activity, thus suppressing the expression of gluconeogenesis 
proteins, including FOXO1, peroxisome proliferator-activated receptor gamma 
coactivator 1 alpha (PGC1α), PEPCK, and glucose 6-phosphatase, in the livers of 
exercise-trained high-fat diet-induced obese mice (Marinho et al., 2012). These studies 
have confirmed that hepatic TRB3 expression responds to acute and chronic exercise 
protocols. Moreover, the reduction in hepatic TRB3 expression in obese mice shows 
beneficial effects on insulin sensitivity under obesity-induced insulin resistance 
conditions.  
Skeletal muscle is the primary site where insulin-stimulated glucose is taken for 
energy storage and utilization. Given the function of TRB3 that inhibits insulin-
stimulated Akt phosphorylation, it rises attentions to study whether the expression of 
TRB3 in skeletal muscle is regulated by exercise and whether TRB3 affects the 
adaptation of exercise-induced skeletal muscle to glucose metabolism. The first study, 
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which measured TRB3 expression in skeletal muscle in response to exercise, 
demonstrates that acute swimming exercise (four sets of 30-minute swimming sessions 
with 5-minute rest periods for a total duration of 2 hours of exercise) reduces TRB3 
expression in skeletal muscle from exercised leptin-deficient ob/ob mice in comparison 
with sedentary ob/ob mice (Matos et al., 2010). The decreased TRB3 expression in the 
skeletal muscle of exercised ob/ob mice restores insulin-stimulated phosphorylation of 
IRS1 and Akt in comparison with sedentary ob/ob mice, leading to higher GLUT4 
expression in the plasma membrane, greater glucose disappearance during insulin 
tolerance test, and increased muscle glycogen content (Matos et al., 2010). However, one 
recent study reports that TRB3 mRNA and protein expression increases in skeletal 
muscle from healthy wild-type mice following 4 weeks of wheel cage exercise (An et al., 
2014). These conflicting results may be due to the use of different species of mice and 
experimental settings, for instance, leptin-deficient ob/ob mice versus healthy wild-type 
mice and swimming versus wheel cage exercises.  
The effect of TRB3 in skeletal muscle on exercise capacity has also been 
investigated using muscle-specific TRB3 transgenic mice. There appears to be no 
difference in insulin-stimulated IRS1 and Akt phosphorylation, or glucose and insulin 
tolerance, in the muscle-specific TRB3 transgenic mice when compared to the wild type 
(An et al., 2014). Interestingly, muscle-specific TRB3 transgenic mice show a 
significantly greater maximal exercise capacity as measured by time-to-exhaustion tests; 
and they also show a greater amount of oxidative fibers than wild-type mice (An et al., 
2014). These data suggest that TRB3 may play a critical role in exercise-induced skeletal 
muscle adaptation and fiber type shifting.  
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2.2 Skeletal muscle mass regulation  
Skeletal muscle shows high plasticity, meaning that it is able to alter and adapt its 
compositions and functions in response to different stimuli, including nutrient and energy 
status, contraction, and growth hormones (Schiaffino et al., 2013). Muscle mass changing 
is one of the most common responses used to demonstrate skeletal muscle flexibility. The 
term hypertrophy refers to increasing muscle mass caused by weight-bearing, balanced 
nutrients, and anabolic hormones; while atrophy refers to reducing skeletal muscle mass 
caused by catabolic signals, including inactivity and malnutrition (Schiaffino et al., 2013; 
Schiaffino & Mammucari, 2011). These conditions of skeletal muscle can be determined 
by measuring the balance between protein synthesis and degradation (Schiaffino et al., 
2013). A positive balance occurs when the protein synthesis rate in skeletal muscle 
exceeds protein breakdown; when this happens, the muscle fibers will increase in size 
(hypertrophy). However, when skeletal muscle maintains a prolonged negative balance, 
the rate of protein degradation is likely to exceed the rate of protein synthesis, resulting in 
atrophic status. The IGF-1)/PI3K/Akt signaling cascade is considered a key mechanism 
in controlling protein turnover in skeletal muscle (Bodine, Stitt, et al., 2001; Latres et al., 
2005; Rommel et al., 2001; Sacheck, Ohtsuka, McLary, & Goldberg, 2004; Schiaffino & 
Mammucari, 2011; Velloso, 2008). Akt (or protein kinase B) is thought to be the master 
regulator of protein turnover in skeletal muscle protein because it stimulates protein 
synthesis via mTOR and protein degradation through the FOXO family (Blaauw et al., 
2009; Rommel et al., 2001; Schiaffino & Mammucari, 2011; Vander Haar, Lee, 
Bandhakavi, Griffin, & Kim, 2007). Therefore, in order to maintain protein turnover and 
skeletal muscle mass in animal and human subjects, it is important to understand how the 
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IGF-1/PI3K/Akt pathway in skeletal muscle regulates protein synthesis and degradation 
and alters skeletal muscle mass.   
 
Protein synthesis via the IGF-1/PI3K/Akt/mTOR pathway 
IGF-1 is an essential growth hormone that induces muscle growth by activating 
the PI3K/Akt pathway (Bodine, Stitt, et al., 2001; Latres et al., 2005; Rommel et al., 
2001; Sacheck et al., 2004; Schiaffino & Mammucari, 2011; Velloso, 2008). Insulin, 
another anabolic hormone, also stimulates the growth of muscle fibers by binding to 
insulin receptors, which activate the same downstream signaling as IGF-1(Bolster, 
Jefferson, & Kimball, 2004; Kitamura et al., 1998). After IGF-1 and insulin bind to their 
receptors, IRS1 is recruited in order to phosphorylate its downstream molecules, PI3K 
and Akt, for activation (Bolster et al., 2004; Latres et al., 2005; Rommel et al., 2001). 
Activated (phosphorylated) Akt can regulate protein synthesis with its downstream 
proteins, mTOR and GSK3b (Glass, 2005; Rommel et al., 2001). First, Akt activation 
indirectly regulates mTOR phosphorylation for increasing protein synthesis in 
consequence of the phosphorylation of tuberous sclerosis complex 2 and proline-rich Akt 
substrate 40 kD (Inoki, Li, Zhu, Wu, & Guan, 2002; Manning, Tee, Logsdon, Blenis, & 
Cantley, 2002; Vander Haar et al., 2007). The phosphorylated mTOR further activates 
and inhibits S6K1 and 4EBP1 by phosphorylation. These processes increase translation 
initiation and elongation, resulting in upregulating protein synthesis (Fingar & Blenis, 
2004; Hara et al., 1997; Rommel et al., 2001). Moreover, the inhibition of mTOR 
activation by rapamycin treatment, a pharmacological compound used as an mTOR 
inhibitor, in cultured myotubes decreases IGF-1-induced phosphorylation of S6K to 
suppress protein synthesis (Rommel et al., 2001; Rommel et al., 1999). In vivo study has 
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also demonstrated that the inhibition of mTOR by rapamycin treatment blocks 
compensatory hypertrophy-induced phosphorylation of Akt, S6K, and 4EBP1 (Bodine, 
Stitt, et al., 2001). Furthermore, skeletal muscle hypertrophy induced by a constitutively 
activated form of Akt to mouse TA muscle is abolished by rapamycin treatment (Bodine, 
Stitt, et al., 2001). In line with this result, Akt transgenic mice display large muscle fiber 
size and enhanced muscle function, including strength (Blaauw et al., 2009; Izumiya et 
al., 2008; Sartori et al., 2009). These findings suggest that the activation of Akt and 
downstream molecules are critical to the stimulation of protein synthesis in response to 
anabolic stimuli, for instance IGF-1 and insulin. 
 
Protein degradation through the IGF-1/PI3K/Akt pathway  
The IGF-1/PI3K/Akt pathway also plays a pivotal role in the regulation of protein 
degradation. Previously, it has been found that muscle-specific IGF-1 overexpression 
promotes hypertrophy and protects against age-related atrophy (Musaro et al., 2001).  
Insulin and/or IGF-1 treatment activates protein synthesis while it suppresses protein 
breakdown, and these processes are mediated by the PI3K/Akt pathway (Monier, Le 
Cam, & Le Marchand-Brustel, 1983; Rommel et al., 2001; Sacheck et al., 2004). In 
atrophic conditions, the PI3K/Akt signaling is suppressed, leading to the inhibition of 
mTOR and the activation of FOXOs (Bodine, Stitt, et al., 2001; Sandri et al., 2004; Stitt 
et al., 2004). FOXOs are a family of forkhead box O transcription factors containing 
three members, FOXO1, FOXO3a, and FOXO4 which are abundant in mammalian cells 
(Tran, Brunet, Griffith, & Greenberg, 2003). As the activation of Akt facilitates protein 
synthesis through the phosphorylation of mTOR in skeletal muscle under anabolic status, 
it can also govern FOXOs activity via phosphorylation in order to inactivate protein 
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degradation. A dephosphorylated form of FOXOs can translocate into the nucleus, where 
it works as a transcription factor, whereas a phosphorylated form is excluded from the 
cytoplasm to be inactivated. The activation of FOXOs, increasing dephosphorylated 
nuclear FOXOs, is required to express muscle-specific E3 ubiquitin ligases such as 
muscle atrophy F box (atrogin-1) and muscle RING finger-1 (MuRF-1). These genes 
encode ubiquitin ligases, which cause ubiquitination to designated protein substrate and 
degradation in skeletal muscle. In addition to the ubiquitin-proteasome system, FOXOs 
can also regulate muscle autophagy-lysosomal protein breakdown (Sandri, 2010). 
Therefore, the regulation of FOXOs by the IGF-1/PI3K/Akt is an important way to 
maintain skeletal muscle mass under atrophic conditions.  
 
Ubiquitin-proteasome system  
Ubiquitination is the process of tagging proteins that are designated for 
degradation with ubiquitin proteins (Finley & Varshavsky, 1985). Protein conjugated 
with ubiquitination undergoes degradation through the 26S proteasome system (Coux, 
Tanaka, & Goldberg, 1996). A few ubiquitin ligases have been identified in the striated 
muscles, where they are responsive to muscle atrophic conditions, including fasting, 
denervation, disuse, and cancer cachexia (Bodine, Latres, et al., 2001; Gomes et al., 2001; 
Lecker et al., 2004; Sacheck et al., 2007). Atrogin-1 and MuRF-1 are muscle-specific 
ubiquitin ligases that increase under muscle wasting conditions, leading to skeletal 
muscle atrophy. Knocking out atrogin-1 in mice causes them to become resistant to 
denervation-induced atrophy (Bodine, Latres, et al., 2001) and fasting-induced muscle 
atrophy (Cong, Sun, Liu, & Tien, 2011), while deletion of MuRF-1 abolishes 
dexamethasone-induced muscle wasting (Baehr, Furlow, & Bodine, 2011). The activation 
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of FOXOs is required for the upregulation of both muscle-specific ubiquitin ligases 
during muscle atrophic conditions (Sandri et al., 2004; Stitt et al., 2004). FOXO1 has 
been identified as necessary for transcription of atrogin-1 and MuRF-1, but it is not alone 
sufficient to induce the transcription of both genes (Stitt et al., 2004). IGF-1 treatment 
can abolish atrogin-1 and MuRF-1 transcriptional activity in response to dexamethasone 
via the blocking of FOXO1 activation (Stitt et al., 2004). Another study has demonstrated 
that FOXO3a is a key regulator of atrogin-1 among downstream proteins of Akt, and that 
constitutively activated FOXO3a in C2C12 myotubes and mouse skeletal muscle 
promotes muscle atrophy through the activation of atrogin-1 promoter (Sandri et al., 
2004). Furthermore, FOXO1 is found to be a main transcription factor in activating 
MuRF-1 promoter activity under dexamethasone-induced atrophy in C2C12 myotubes 
(Waddell et al., 2008). This effect of FOXO1 on MuRF-1 expression is blocked by IGF-1 
treatment via the activation of the PI3K/Akt pathway (Sacheck et al., 2004). Recently, 
triple FOXOs muscle-specific knockout mice, the deletion of FOXO1, 3a, and FOXO4, 
have demonstrated that FOXOs are required to induce the expression of atrophy-related 
ubiquitin ligase genes; and these mice prevent loss of skeletal muscle mass and function 
from fasting- and denervation-induced skeletal muscle atrophy (Milan et al., 2015). 
Altogether, these data suggest that FOXOs activity is a major player in the regulation of 
muscle-specific ubiquitin ligase expression under atrophic conditions; and that this 
expression can be prevented by the activation of Akt signaling.  
 
Autophagy-lysosomal system  
Autophagy is a highly conserved homeostatic process that breaks down and 
recycles cell components through lysosomal machinery in response to cellular stress 
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(Sandri, 2010). Increased rates of autophagy have been observed in skeletal muscle under 
various stimuli, including cancer (Penna et al., 2013), aging (Sandri, 2010, 2013), 
nutrient restriction (Mizushima, Yamamoto, Matsui, Yoshimori, & Ohsumi, 2004), 
muscle disuse and denervation (Brocca et al., 2012; Mammucari et al., 2007; O'Leary, 
Vainshtein, Carter, Zhang, & Hood, 2012; Zhao et al., 2007). Skeletal muscle that has 
undergone fasting or denervation induces the expressions of autophagy markers, such as 
microtubule-associated protein 1 light chain 3B (LC3B), Bnip3, and Atg4b; while the 
upregulation of autophagy genes is completely abolished in mice expressing the 
constitutively active form of Akt (Mammucari et al., 2007). Moreover, like ubiquitin-
proteasome genes, FOXO3a has shown involvement in the regulation of autophagic 
markers. Constitutively activated FOXO3a promotes LC3B transcriptional activity to 
increase the formation of autophagosome, which then increases lysosomal proteolysis; 
while the inhibition of FOXO3a by RNAi blocks fasting-induced autophagy in mouse 
skeletal muscle (Mammucari et al., 2007). The triple FOXOs muscle-specific knockout 
mice have decreased fasting- and denervation-induced lipidation and autophagosome 
vesicle formation via LC3B and p62 expression (Milan et al., 2015). Taken together, 
these results imply that FOXOs play a pivotal role in lysosomal autophagosome 
proteolysis system; and the activity of Akt is critical to the regulation of the proteolytic 
system in skeletal muscle via management of FOXOs activity.   
 
Fasting-induced skeletal muscle atrophy  
Prolonged starvation destroys the balance between anabolism and catabolism in 
the system, resulting in increasing degradation of tissues that store energy sources, 
including fat, liver, and skeletal muscle. Skeletal muscle contains a great number of 
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proteins which can be utilized to maintain blood glucose levels via gluconeogenesis in 
the liver when the body undergoes severe catabolism due to fasting or diseases. It has 
been demonstrated that fasting over 12 hours reduces ~ 20% of body weight and skeletal 
muscle mass in rodent models (Garlick et al., 1975; Li & Goldberg, 1976). In addition to 
mass changes, the rate of protein degradation is critically elevated while the rate of 
protein synthesis is suppressed (Garlick et al., 1975; Li & Goldberg, 1976). Fasting has 
been associated with an increase in E3 ubiquitin ligases, such as atrogin-1 and MuRF-1, 
which are regulated by suppressed Akt and activated FOXOs signaling (Dehoux et al., 
2004; Gomes et al., 2001; Jagoe, Lecker, Gomes, & Goldberg, 2002; Sandri et al., 2004). 
In vitro experiments have confirmed that the incubation of PBS for 6 hours, which 
mimics fasting conditions, impairs phosphorylation of Akt and S6K1 while FOXOs is 
activated (Sandri et al., 2004). Furthermore, the activation of FOXOs links to the 
activation of atrogin-1 and MuRF-1 in C2C12 myotubes and mouse skeletal muscle 
(Gomes et al., 2001; Sandri et al., 2004). Starvation has also been shown to induce 
lysosomal-autophagosome proteolysis in rodent models. One-day food deprivation 
disrupts Akt and its downstream proteins, mTOR and FOXO, signaling to accelerate 
protein degradation; while autophagy-related genes, including LC3B and Bnip3, are 
simultaneously activated to a high degree(Mammucari et al., 2007). This fasting-induced 
autophagy is inhibited in mouse skeletal muscle with overexpressed Akt, whereas the 
dominant negative form of FOXO3a completely abolishes fasting-induced 
autophagosome formation in mouse skeletal muscle (Mammucari et al., 2007). These 
findings support the hypothesis that food deprivation over 12 hours is sufficient to 
provoke skeletal muscle atrophy through the activation of ubiquitin-proteasome and 
lysosomal-autophagosome proteolysis.  
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2.3 Exercise-induced skeletal muscle adaptation  
Skeletal muscle plasticity responds not only to the balance between anabolism 
and catabolism, but also to contractile activity. Regular physical activity is associated 
with increasing repeated sporadic muscle contraction, which is considered a foundation in 
the prevention, management, and treatment of chronic metabolic diseases, such as 
T2DM, obesity, and cancer (Haskell et al., 2007).  Physical activity has been successful 
in delaying complications and improving symptoms of diseases, which in turn reduces 
the individual’s burden of healthcare cost. Exercise has also been shown to contribute to 
skeletal muscle physiological adaptation, for example, maintaining or gaining muscle 
mass, increasing the shift in fiber type from glycolytic to oxidative, improving glucose 
metabolism, and increasing the efficiency of oxidative phosphorylation (Egan & Zierath, 
2013; Phillips, Green, Tarnopolsky, Heigenhauser, & Grant, 1996) . These beneficial 
outcomes vary depending on the type (endurance vs. resistance), duration (acute vs. 
chronic), and intensity (low to high) of the exercise sessions (Ferraro, Giammarioli, 
Chiandotto, Spoletini, & Rosano, 2014; Nader & Esser, 2001). In general, exercise-
induced adaptations originate from alterations of gene expression, protein contents, and 
enzymatic activities. These active changes are involved in myogenesis, carbohydrate and 
fat utilization and metabolism, mitochondrial oxidative metabolism, and mitochondrial 
biogenesis (Booth & Thomason, 1991; Mahoney et al., 2005; Pilegaard, Saltin, & Neufer, 
2003). As a result, these progressions enable working muscle to efficiently utilize and 
deliver substrates and to maximize mitochondrial respiratory capacity, resulting in 
optimal performance and enhanced homeostatic maintenance to resist fatigue (Egan & 
Zierath, 2013). 
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Exercise-induced glucose homeostasis and insulin sensitivity  
Continuous contractile activity, which exercise can elicit, has been associated 
with improved glucose metabolism in human and rodent models (Booth & Thomason, 
1991; Dela et al., 2006; Ferraro et al., 2014). Exercise-induced glucose uptake was first 
explored in animal models using a single bout of swimming exercise or electrical 
stimulation. Contracting rat hindlimb muscles elevates the rate of glucose uptake in 
comparison with control muscle, both in the absence and presence of insulin; but 
stimulated muscles are more likely to be sensitive to insulin infusion (Ivy & Holloszy, 
1981; Richter, Garetto, Goodman, & Ruderman, 1984). This result has been confirmed in 
human subjects as well (Mikines, Sonne, Farrell, Tronier, & Galbo, 1988; Richter et al., 
1989). In this regard, exercise has proven its role as a medicine by effectively improving 
glucose tolerance and increasing insulin sensitivity in normal, insulin resistance, and 
aging skeletal muscle (Castorena, Arias, Sharma, & Cartee, 2014; Ivy, 1997; Kahn et al., 
1990; Kjobsted et al., 2017).  
Exercise-induced improvements in glucose metabolism and insulin sensitivity are 
associated with increasing expressions and functions of glucose transporters and 
metabolic enzymes in skeletal muscle. It has been demonstrated that a single bout of 
exercise can increase GLUT4 mRNA expression and protein expression in rat skeletal 
muscle (Kuo, Hunt, Ding, & Ivy, 1999; Neufer, Shinebarger, & Dohm, 1992); however, 
not all studies demonstrate the same effects (Funai & Cartee, 2009; Hansen, Nolte, Chen, 
& Holloszy, 1998). In human skeletal muscle, GLUT4 mRNA expression is increased 
immediately post-exercise (Kraniou, Cameron-Smith, & Hargreaves, 2006; McGee & 
Hargreaves, 2004), although varied results of GLUT4 protein expression have been 
observed (Frosig, Pehmoller, Birk, Richter, & Wojtaszewski, 2010; Kraniou et al., 2006; 
 34 
Leick et al., 2010). Exercise-increased glucose uptake occurs after exercise in both 
insulin-dependent and independent conditions. Acute and chronic exercise induces 
insulin-stimulated glucose uptake (G. D. Cartee et al., 1989; Frosig et al., 2007; Gulve, 
Cartee, Zierath, Corpus, & Holloszy, 1990) by increasing insulin-stimulated GLUT4 
translocation (Hansen et al., 1998). Insulin-mediated GLUT4 translocation has been 
found to be associated with the Rab GTPase-activating protein Akt substrate of 160 kDa 
(AS160; also known as TBC1D4) (G. D. Cartee & Wojtaszewski, 2007; Kramer et al., 
2006). In the absence of insulin, phosphorylated AS160 is higher in the exercised group 
and it remains higher than in the sedentary group for up to 14 hours (Arias, Kim, Funai, 
& Cartee, 2007; Frosig et al., 2007). Furthermore, insulin treatment subsequently 
stimulates the phosphorylation of AS160 via Akt phosphorylation (Arias et al., 2007; 
Funai, Schweitzer, Sharma, Kanzaki, & Cartee, 2009). This insulin-dependent exercise-
induced glucose uptake can be completely inhibited by a PI3K inhibitor, suggesting that 
the PI3K/Akt pathway is a key mechanism in regulating exercise-induced glucose 
disposal and metabolism (Funai & Cartee, 2009; Wojtaszewski, Hansen, Kiens, & 
Richter, 1997).  
Another mechanism of exercise-induced glucose uptake is the elevation of the 
ADP/ATP ratio and Ca2+ influxes in working muscle fibers, which results in activated 
adenosine monophosphate-activated protein kinase (AMPK) (Egan et al., 2010; Merrill, 
Kurth, Hardie, & Winder, 1997; Wojtaszewski et al., 2003). A paralog Rab GAP of 
AS160, TBC1D1, has shown involvement in exercise-induced glucose transport and is 
activated by insulin, muscle contraction, and the AMPK-activator AICAR (Funai & 
Cartee, 2009; Taylor et al., 2008). Furthermore, AMPK has shown to be important in 
mediating contraction-induced phosphorylation of TBC1D1 and glucose transport (Funai 
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& Cartee, 2009). Therefore, the activation of AMPK through contractile activity assists in 
exercise-induced glucose uptake and metabolism.  
In addition to exercise-induced GLUT4 expression and translocation, the elevated 
expression and function of metabolic enzymes contributes to improved glucose 
homeostasis after exercise (Egan & Zierath, 2013; Ferraro et al., 2014). Hexokinase II is 
a rate-limiting enzyme used in glycolysis to convert glucose to glucose-6-phosphate, 
which is a suitable form for transportation into the cytoplasm, where it can be further 
metabolized (Wilson, 2003). It has been reported that even a single bout of exercise can 
increase hexokinase II mRNA expression and enzymatic activity in rat skeletal muscle 
(O'Doherty, Bracy, Granner, & Wasserman, 1996; O'Doherty et al., 1994). Previous 
studies using muscle-specific hexokinase II transgenic mouse models demonstrate that 
hexokinase II overexpression in skeletal muscle improves exercise-induced and insulin-
stimulated glucose uptake (Fueger et al., 2004; Halseth, Bracy, & Wasserman, 1999). 
Furthermore, hexokinase II expression and activity are a determinants of exercise-
induced glucose uptake. It has been shown that skeletal muscle glucose uptake, glucose 
oxidation rate, and exercise capacity are impaired in hexokinase II knockout mice(Fueger 
et al., 2003; Fueger et al., 2005).  
 
Exercise-induced oxidative capacity and muscle fiber type shifting 
Endurance exercise training improves oxidative capacity and metabolic efficiency 
in skeletal muscle. This benefit is elicited by increased mitochondrial content resulting 
from the regulation of protein expressions and transcriptional activities pertaining to 
transport and oxidation of energy substrates (Baar et al., 2002; Pilegaard et al., 2003). 
Mitochondrial adaptation begins with mitochondrial biogenesis defined by an elevation in 
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mitochondria number and size, and an increase in efficiency of mitochondrial capacity. 
Nuclear respiratory factor (NRF) -1 and NRF-2 have been identified as promoting gene 
expression associated with components of the electron transport chain and mitochondrial 
biogenesis (Scarpulla, 2002). Moreover, PGC-1a is highlighted as a key regulator of 
mitochondrial biogenesis in skeletal muscle (Baar et al., 2002; Pilegaard et al., 2003). It 
has been demonstrated that acute and chronic endurance exercise induces PGC-1a 
mRNA and protein expression in animal and human models, with the level of expression 
dependent on exercise intensity (Baar et al., 2002; Edgett et al., 2013; Egan et al., 2010; 
Meirhaeghe et al., 2003; Pilegaard et al., 2003). 
In addition to exercise-induced oxidative capacity via the alteration of these 
transcriptional factors, the transformation of skeletal muscle fiber permits adaptation in 
oxidative capacity. Skeletal muscle fibers vary in structural and metabolic characteristics 
(Qaisar, Bhaskaran, & Van Remmen, 2016). Depending on myosin heavy chain isoforms 
diversity, muscle fiber types in rodents can be divided into four group: slow-twitch 
oxidative type I, fast-twitch and oxidative type IIa, fast-twitch and glycolytic type IIb/x, 
and fast-twitch and highly glycolytic type IIb (Rivero, Talmadge, & Edgerton, 1998, 
1999; Termin, Staron, & Pette, 1989). Humans express all the same isoforms as rodents 
except type IIb (Ennion, Sant'ana Pereira, Sargeant, Young, & Goldspink, 1995). 
Research has shown that endurance exercise promotes fiber type shifting among fast-
twitch fibers from glycolytic type IIb and IIb/x fiber to oxidative type IIa fiber (Green, 
Thomson, Daub, Houston, & Ranney, 1979). PGC-1a plays an essential role in 
transforming muscle fiber types induced by exercise. Studies of mice with muscle-
specific PGC-1a overexpression show that the mice improve in exercise capacity and 
contain more slow-twitch and oxidative fibers (Calvo et al., 2008; Lin et al., 2002), while 
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whole-body or muscle-specific PGC-1a  knockout mice demonstrate decreased oxidative 
fiber types and properties in skeletal muscle (Handschin et al., 2007; Leone et al., 2005). 
However, it has been reported that muscle-specific PGC-1a mice retain the capability for 
exercise-induced fiber type shifting just as wild-type mice do, suggesting that the roles of 
PGC-1a in skeletal muscle and exercise-induced fiber type transformation are not yet 
completely understood (Geng et al., 2010)
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CHAPTER 3 
TRIBBLES 3 REGULATES PROTEIN TURNOVER IN MOUSE SKELETAL 
MUSCLE1
                                                             
1 Choi RH, McConahay A, Jeong HW, McClellan JL, Hardee JP, Carson JA, Hirshman MF, Goodyear LJ, 
Koh HJ. 2017. Biochemical and Biophysical Research Communications. 493:1236-1242. 
Reprinted here with permission of publisher. 
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3.1 ABSTRACT 
Skeletal muscle atrophy is associated with a disruption in protein turnover 
involving increased protein degradation and suppressed protein synthesis. Although it has 
been well studied that the IGF-1/PI3K/Akt pathway plays an essential role in the 
regulation of the protein turnover, molecule(s) that triggers the change in protein turnover 
still remains to be elucidated. TRB3 has been shown to inhibit Akt through direct 
binding. In this study, we hypothesized that TRB3 in mouse skeletal muscle negatively 
regulates protein turnover via the disruption of Akt and its downstream molecules. 
Muscle-specific TRB3 transgenic (TRB3TG) mice had decreased muscle mass and fiber 
size, resulting in impaired muscle function. We also found that protein synthesis rate and 
signaling molecules, mTOR and S6K1, were significantly reduced in TRB3TG mice, 
whereas the protein breakdown pathway was significantly activated.  In contrast, TRB3 
knockout mice showed increased muscle mass and had an increase in protein synthesis 
rate, but decreases in FoxOs, atrogin-1, and MuRF-1. These findings indicate that TRB3 
regulates protein synthesis and breakdown via the Akt/mTOR/FOXOs pathways.  
Key words: TRB3, protein degradation, protein synthesis, atrophy 
 
3.2 INTRODUCTION 
 Skeletal muscle plays many important roles in general health, including whole-
body metabolism and mobility not only in the elderly but also in young individuals 
(Goodpaster et al., 2006). Moreover, reduced muscle mass resulting from several critical 
conditions, such as diabetes, cancer, and obesity, has substantially contributed to poor 
quality of life and increased mortality (Martin et al., 2013; Rantanen et al., 2000; 
Wannamethee, Shaper, Lennon, & Whincup, 2007). Therefore, a better understanding of 
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the signaling molecules that regulate muscle mass could enhance future treatments and 
significantly reduce a healthcare burden. 
 The maintenance of muscle mass is a direct consequence of muscle protein 
turnover, involving the homeostatic regulation of protein accretion and breakdown and it 
directly impacts muscle growth and atrophy. Insulin and insulin-like growth factor-1 
(IGF-1) are key anabolic hormones that regulate muscle protein homeostasis through the 
PI3K/Akt signaling pathway (Latres et al., 2005; Rommel et al., 2001; Velloso, 2008). 
Particularly, Akt controls both anabolic and catabolic signals in skeletal muscle via its 
downstream proteins, mammalian target of rapamycin (mTOR) and forkhead box O 
families (FOXOs), respectively (Bodine, Stitt, et al., 2001; Rommel et al., 2001; Sandri et 
al., 2004; Stitt et al., 2004). mTOR mediates protein synthesis through the 
phosphorylation of ribosomal S6 kinase 1 (S6K1) and 4EBP1, and it promotes cell 
proliferation and growth in response to anabolic stimuli, including insulin, IGF-1, and 
nutrients (Proud, 2004; Rommel et al., 2001). On the other hand, FOXOs regulate 
catabolic processes and their activities are suppressed by the activation of Akt (Brunet et 
al., 1999). FOXOs activates protein breakdown in skeletal muscle through the ubiquitin-
proteasome system by upregulating the expression of two muscle-specific E3 ubiquitin 
ligases, atrogin-1 and MuRF-1, also called atrogenes (Sandri et al., 2004; Stitt et al., 
2004). However, signaling molecules that regulate protein turnover in the IGF-
1/PI3K/Akt pathway have not been fully described. 
 A mammalian Drosophila tribbles homolog 3 (TRB3) is a pseudokinase that lacks 
an enzymatic domain of protein kinase (Du et al., 2003). Multiple tissues including 
skeletal muscle have displayed an increase in expression of TRB3 under various stressful 
conditions, such as fasting, ER stress, and insulin resistance (Du et al., 2003; Kato & Du, 
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2007; Koh et al., 2013; Liew et al., 2010; Qi et al., 2006). In mouse myoblast C2C12 
cells, TRB3 overexpression directly disrupts Akt signaling and delays muscle cell 
differentiation (Kato & Du, 2007). In vivo studies have established that TRB3 regulates 
glucose homeostasis and ER stress-induced insulin resistance in skeletal muscle by 
inhibiting Akt activity (Koh et al., 2013). Although numerous studies have demonstrated 
that TRB3 negatively regulates the Akt signaling pathway to influence metabolism, 
TRB3’s effects on downstream pathways of Akt, such as protein synthesis and 
breakdown, in skeletal muscle have not been elucidated.  
  In the present study, we hypothesized that overexpression of TRB3 would disrupt 
protein turnover through the suppression of Akt activation in skeletal muscle. Our 
findings show that muscle-specific TRB3 transgenic (TRB3TG) mice exhibited impaired 
muscle function and decreased muscle mass, resulting from suppressed mTOR/S6K1 
signaling and increased FOXO1 and FOXO3a activation. Further, the mRNA expression 
of atrogin-1 and MuRF-1 was elevated in TRB3TG mice. In contrast, the TRB3 knockout 
mice tended to have increased muscle mass and protein synthesis rate, while the mRNA 
expression of atrogenes was significantly suppressed. These results suggest that TRB3 
plays a prominent role in the regulation of skeletal muscle protein balance and function. 
 
3.3 MATERIALS AND METHODS 
Animal Care and Use 
 Female (10-11-week-old) C57BL/6 wild type (WT), TRB3TG (An et al., 2014), 
and whole-body TRB3 knockout (TRB3KO) mice (Koh et al., 2013; Okamoto et al., 
2007) were used for all experiments. All animals were maintained on a standard chow 
diet (no. 8604, Harlan Teklad Diet, Madison, WI, USA) and allowed ad libitum access to 
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food and water. They were housed under 12 h (7AM – 7PM) of light per day in 
temperature-controlled environment. All protocols were approved by the Institutional 
Animal Care and Use Committee of the University of South Carolina.  
 
Western Blot Analysis  
 Gastrocnemius (GAS) muscles were collected and protein lysates were prepared 
for Western blot analysis as previously described (Fujii et al., 2004; Koh et al., 2013).  
Primary and secondary antibodies were purchased from commercial sources, including p-
Akt Thr308 (9275) and Ser473 (9271), Akt (9272), p-mTOR Ser2448 (2971), mTOR (2972), 
p-S6K1 Thr389 (9205), S6K1 (9202), p-FOXO1 Ser256 (9461), FOXO1 (2880), p-
FOXO3a Ser253 (13129), FOXO3a (12829), GAPDH (2118) from Cell Signaling 
Technology (Danvers, MA, USA), Atrogin-1 (AP2041), MuRF-1 (MP3401) from ECM 
(Versailles, KY, USA), TRB3 (ST1032; Calbiochem, San Diego, CA, USA), anti-
puromycin (MABE343; EDM Millipore Billerica, MA, USA), anti-rabbit (NA934; GE 
healthcare, Pittsburgh, PA, USA) IgG- and anti-mouse (61-0220; Invitrogen, Carlsbad, 
CA, USA) IgG2a-horesradish peroxidase conjugated secondary antibodies. The specific 
bands were visualized using ECL reagents (NEL105001EA; PerkinElmer, Waltham, MA, 
USA), and the intensity of bands was quantified using Image Studio Lite (LI-COR 
Biosciences, Lincoln, NE, USA).  
Real-Time Polymerase Chain Reaction Analysis  
 Tibialis anterior (TA) muscles were used for real-time PCR analysis as previously 
described (Koh et al., 2013). Total RNA was extracted using Trizol reagent (15596018; 
Life Technologies, Carlsbad, CA, USA) and cDNA was synthesized from 4 μg of total 
RNA by High Capacity cDNA kit (Life Technologies, Carlsbad, CA, USA). SYBR green 
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PCR master mix (4309155; Life Technologies, Carlsbad, CA, USA) carried cDNA and 
primers. Primer sequences were as follows: TBP forward, 5’-
ACCCTTCACCAATGACTCCTATG-3’, and TBP reverse, 5’-
TGACTGCAGCAAATCGCTTGG-3’; TRB3 forward, 5’-
TCTCCTCCGCAAGGAACCT-3’, and TRB3 reverse, 5’-
TCTCAACCAGGGATGCAAGAG-3’; Atrogin-1 forward, 5’-
GCAGAGAGTCGGCAAGTC-3’, and Atrogin-1 reverse, 5’-
CAGGTCGGTGATCGTGAG-3’; MuRF-1 forward, 5’-
GGAACCTGCTGGTGGAAAACATC-3’, and MuRF-1 reverse, 5’-
CGTCTTCGTGTTCCTTGCACATC-3’; Cathepsin-L forward, 5’-
GTGGACTGTTCTCACGCTCAAGG-3’, and Cathepsin-L reverse, 5’-
TCCGTCCTTCGCTTCATAGGT-3’. TBP expression served as an internal control and 
relative levels of mRNA expression were normalized to its expression. 
In vivo Protein Synthesis Measurement  
 The rate of in vivo protein synthesis was determined by measuring puromycin 
incorporation into a nascent peptide as previously described (Goodman et al., 2011). 
Briefly, mice received an intraperitoneal injection of 0.04 μmol/g body weight with 
puromycin (540411; EDM Millipore, Billerica, MA, USA) dissolved in 100 μl of PBS 30 
minutes before euthanasia. Tissues were collected and stored at -80 °C for future 
analysis. Western blot was used to determine the amount of puromycin incorporation.   
Muscle Cross-Sectional Area Analysis 
 Frozen TA muscles were sectioned (10-μm) on a cryostat microtome and affixed 
to slides. Sections were stained with hematoxylin and eosin according to a previous study 
(Hardee et al., 2016; McClung, Davis, Wilson, Goldsmith, & Carson, 2006). Fibers were 
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analyzed by ImageJ 1.48v (National Institutes of Health, Bethesda, MD, USA). 
Approximately 200 fibers were traced per sample, as determined by a plateau in standard 
deviation in order to determine the proximate fiber number and cross-sectional area.  
Statistical Analysis  
 Data are expressed as means ± standard error of the mean. Student t-test and two-
way ANOVA followed by the Bonferroni Post hoc analysis were used to determine 
significance. P < 0.05 was considered statistically significant.  
 
3.4 RESULTS 
Muscle-specific overexpression of TRB3 decreases skeletal muscle mass and impairs 
muscle function 
 To determine the effects of TRB3 on skeletal muscle mass and function, we 
studied TRB3TG mice that have previously been examined (An et al., 2014). The 
expression of TRB3 mRNA and protein was significantly elevated in TA and GAS, 
respectively, confirming the overexpression in mouse skeletal muscle (Fig. 3.1A and B). 
Body weights were similar between WT and TRB3TG mice (Fig. 3.1C). However, 
TRB3TG mice showed a significant decrease in muscle mass (Fig. 3.1D). TRB3TG mice 
also displayed a significantly lower (16%) grip strength compared to WT (Fig. 3.1E). 
Furthermore, we individually housed WT and TRB3TG mice in wheel cages for 8 weeks 
to examine the capacity of voluntary wheel exercise. TRB3TG mice performed poorly 
with a 46% decrease in total running distance compared to WT (Fig. 3.1F). Taken 
together, these data suggest that TRB3 plays important roles in skeletal muscle mass 
regulation and function.  
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TRB3 decreases muscle cross-sectional area in mouse skeletal muscle 
 To investigate if the decreased muscle mass in TRB3TG mice is associated with 
an alteration in fiber size, we measured the cross-sectional area (CSA) in WT and 
TRB3TG mice. Consistent with decreased muscle weight (Fig. 3.1D), TRB3TG mice 
showed a marked decrease (23%) in mean CSA compared to WT (Fig. 3.1G and H). 
Furthermore, the percentage of fibers less than 1000 μm2 was increased in TRB3TG 
mice, while WT littermates were likely to have larger fibers (Fig. 3.1I). These data 
indicate that TRB3 adversely affects myofiber size in mouse skeletal muscle. 
TRB3TG mice display a decrease in protein synthesis  
 Given that TRB3TG mice had a decrease in muscle mass compared to WT, we 
next determined if TRB3 overexpression affects signaling molecules involved in protein 
synthesis. We have previously shown that overexpression of TRB3 in C2C12 myotubes 
decreases insulin-stimulated Akt phosphorylation through direct binding to Akt (Koh et 
al., 2006; Koh et al., 2013). To determine the effect of TRB3 on protein synthesis in 
skeletal muscle, we studied Akt-regulated downstream proteins, mTOR/S6K1. 
Overexpression of TRB3 significantly decreased mTOR phosphorylation at Ser2448 
compared to WT (Fig. 3.2A). Consistent with reduced mTOR phosphorylation, the 
phosphorylation of S6K1 was substantially suppressed (60%) in TRB3TG mice (Fig. 
3.2B). Basal Akt phosphorylation at Thr308 and Ser473 was not different between groups 
(Fig. 3.2C and D). To determine how decreased mTOR/S6K1 signaling affects the rate of 
protein synthesis, WT and TRB3TG mice were given an intraperitoneal injection of 
puromycin, a structural analog of tyrosyl-tRNA, to measure the rate of protein synthesis 
as previously described (Goodman et al., 2011). The protein synthesis rate was reduced in 
EDL (20%) and SOL (60%) muscles from TRB3TG mice compared to the muscles from 
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WT (Fig. 3.2E–G). We further tested the signaling molecules involved in protein 
synthesis and measured the rate of protein synthesis in TRB3KO mice. Although the 
level of phosphorylated mTOR was slightly higher in the TRB3KO group (Fig. 3.3A), we 
did not observe a significant difference in the Akt/mTOR/S6K1 signaling in TRB3KO 
mice compared to WT (Fig. 3.3A–D). The rate of protein synthesis in SOL muscle in 
TRB3KO mice was higher than that of WT (Fig. 3.3G), although there was no difference 
in protein synthesis rate in EDL muscle (Fig. 3.3F). Moreover, the muscle weights of 
TRB3KO mice were increased (Fig. 3.3H and I) compared to WT, without a change in 
body weight (unpublished observations by RH Choi and HJ Koh). These results 
demonstrate that TRB3 regulates the anabolic signaling pathway and the rate of protein 
synthesis in mouse skeletal muscle. 
TRB3TG mice have activated protein degradation and increased atrogin-1 and MuRF-
1 mRNA expression  
 We next determined if TRB3 affects the protein degradation pathway, including 
the FOXOs and the muscle-specific E3 ubiquitin ligases, atrogin-1 and MuRF-1. 
TRB3TG mice showed a decrease in phosphorylation of FOXO1 and FOXO3a compared 
to WT, indicating activated FOXO signaling (Fig. 3.4A and B). Interestingly, the mRNA 
expression of MuRF-1 was significantly elevated, and there was a tendency (P=0.07) to 
increase the atrogin-1 expression in TRB3TG mice without a change in cathepsin L 
mRNA expression, a marker for lysosomal protease (Fig. 3.4C). FOXO1 and FOXO3a 
activities were inhibited in TRB3KO mice compared with WT (Fig. 3.4D and E). These 
results also coincided with a significant reduction in atrogin-1 and MuRF-1 mRNA 
expression, whereas cathepsin L was not altered (Fig. 3.4F). Taken together, these data 
indicate that TRB3 regulates FOXOs and protein degradation pathway. 
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3.5 DISCUSSION 
 The balance between anabolic and catabolic signal is critical to maintain muscle 
mass. Akt, a key protein kinase in insulin signaling, regulates both protein synthesis and 
degradation pathways. However, it has not yet been clearly elucidated what molecule(s) 
may regulate Akt signaling. In the current study, we found that TRB3TG mice had 
reduced muscle mass, decreased fiber size, and impaired muscle function. Protein 
synthesis rate and signaling molecules, mTOR and S6K1, were significantly decreased in 
TRB3TG mice. Furthermore, atrogin-1 and MuRF-1 were highly increased in TRB3TG 
mice compared to WT, indicating an activation of protein degradation. In addition, 
TRB3KO mice displayed increased muscle mass and also elevated protein synthesis rate, 
while the protein degradation pathway was significantly suppressed. Taken together, 
these findings suggest that TRB3 plays a prominent role in the regulation of protein 
turnover.  
 Given the proposed role of TRB3 in the inhibition of Akt signaling (Du et al., 
2003; Koh et al., 2006; Koo et al., 2004), our findings demonstrate that TRB3 expression 
in skeletal muscle affects Akt downstream proteins, including mTOR and FOXOs, in 
order to regulate protein balance. The decreased mTOR/S6K1 phosphorylation and 
protein synthesis rate in TRB3TG mice were associated with increased FOXOs activation 
and atrogenes expression, which may influence the reduced muscle mass. We believe that 
the decreased muscle mass and function in TRB3TG mice is due, at least in part, to the 
negative regulation of the Akt/mTOR/FOXOs signaling. Earlier studies have reported 
that the effect of TRB3 on the inhibition of Akt is related to metabolic dysfunctions, such 
as insulin resistance and glucose intolerance (Du et al., 2003; Koh et al., 2013). However, 
the regulation of downstream pathways of Akt by TRB3 has not been directly tested. Our 
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findings support the hypothesis that TRB3 negatively regulates Akt downstream 
signaling in mouse skeletal muscle at basal state to disrupt protein balance, leading to a 
suppression of protein synthesis and an activation of protein breakdown. In the present 
study, we examined the basal Akt phosphorylation and did not detect a decreased Akt 
phosphorylation in TRB3TG (Fig 3.2C and D). Given that Akt is activated by anabolic 
stimulants, such as insulin and IGF-1 (Downward, 1998), it is possible that the marginal 
difference of basal Akt phosphorylation in TRB3TG mice was undetectable by the 
Western blot analysis. Our previous study and others have used insulin treatment to 
demonstrate that Akt activation is impaired by TRB3 expression while the level of Akt 
phosphorylation was not different at basal level (Koh et al., 2013; Zhang et al., 2013). For 
future studies, it will be necessary to determine Akt activation and its downstream 
signaling molecules in TRB3TG mice at both basal and insulin-stimulated conditions to 
find a link between Akt activity and protein turnover pathways. 
In contrast to our findings, An et al. have reported that overexpression of TRB3 in 
skeletal muscle results in greater muscle mass in TA, SOL, and GAS and contains more 
oxidative muscle fibers (An et al., 2014). The reasons for the discrepancy are not clear. It 
is possible that different genetic backgrounds resulted in different phenotypes. The 
TRB3TG mice were generated in the embryos with mixed background (Qi et al., 2006). 
Mice carrying the TRB3 transgene on the mixed background were backcrossed three to 
four times to C57BL/6 WT mice before used for the previous experiments (An et al., 
2014). We continued to backcross the TRB3TG mice with C57BL/6 WT mice additional 
three times (six to seven times in total) for the present experiments. In addition, the 
inconsistent phenotypes might also result from different diet between the previous study 
(Harlan Teklad Diet #8604) and current study (LabDiet Mouse Diet 9F) as different diet 
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may affect study outcomes, including phenotypes of animal models (Reliene & Schiestl, 
2006). Another contradict to previous report is exercise capacity in TRB3TG mice. An et 
al. has revealed TRB3 transgenic mice increased maximal running capacity compared to 
WT whereas ours showed significantly decreased total running distance on 8 weeks of 
voluntary wheel exercise (An et al., 2014). In addition to the different genetic 
backgrounds and diets, different exercise capacity results may be due to the different 
exercise testing protocol. We utilized voluntary wheel cage running for 8 weeks and 
measured total running distance, but maximal time-to-exhaustion treadmill protocol was 
applied in the previous experiment and they analyzed maximal exercise capacity in total 
work. Therefore, depending on the purpose of testing, these two different measurements 
would produce different results, and it is possible that the same animal model could 
respond differently as previously described (Y. F. Liu et al., 2009; Noble et al., 1999).  
 In summary, our results demonstrate that TRB3 overexpression in skeletal muscle 
decreased muscle weight and impaired muscle function that were associated with 
decreased protein synthesis and increased protein breakdown. Our results suggest that 
TRB3 plays a key role in muscle mass balance through regulating protein synthesis and 
breakdown pathways.  
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Figure 3.1 Effects of TRB3 on muscle mass and function in mice. (A-B) Ten- to 
eleven-week-old female wild type (WT) and muscle-specific TRB3 transgenic (TG) mice 
were used to determine TRB3 mRNA and protein expression from tibialis anterior and 
gastrocnemius, respectively. (C) Body weight was similar between WT and TG. (D) 
Weights of tibialis anterior (TA), extensor digitorum longus (EDL), soleus (SOL), and 
gastrocnemius (GAS) muscles were measured. (E-F) Muscle function was evaluated by 
measuring grip strength and voluntary wheel exercise capacity for 8 weeks. (G) Frozen 
TA muscles were sectioned in 10-μm-thickness by a cryostat microtome and stained with 
hematoxylin and eosin. Original magnification: x400; scale bar: 50 μm. (H) Fibers were 
traced and analyzed by ImageJ in order to determine the mean CSA. (I) The frequency 
distribution of the fibers in wild type and TRB3TG mice was determined. Data are the 
means ± S.E.M (n = 5-6 per group). * P < 0.05, ** P < 0.01 vs. WT  
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Figure 3.2 Effect of TRB3 overexpression on protein synthesis in mouse skeletal 
muscle. GAS muscles were collected from WT and TRB3TG mice. (A-D) The 
activations of signaling molecules related to protein synthesis, including mTOR (A), 
S6K1 (B), and Akt (C and D), were analyzed by Western blot. (E-G) After 5 hours of 
fasting, mice received an intraperitoneal injection of 0.04 μmol/g body weight with 
puromycin dissolved in 100 μl of PBS 30 min before euthanasia to measure the rate of 
protein synthesis. Western blot was used to measure the amount of puromycin 
incorporation into nascent peptides. (E) Ponceau S staining of puromycin analysis from 
SOL muscle showed that proteins were equally loaded. EDL (F) and SOL (G) muscles 
were analyzed. Data are the means ± S.E.M. (n = 5-6 per group). * P < 0.05, ** P < 0.01, 
*** P < 0.001 vs. WT 
WT TG
0.0
0.5
1.0
1.5
pm
TO
R
S2
44
8 /m
TO
R
 (A
.U
.)
pmTORS2448
mTOR
WT   TG    WT     TG
***
WT TG
0.0
0.5
1.0
1.5
pS
6K
1T
38
9 /S
6K
1 
(A
.U
.)
pS6K1T389
S6K1
WT   TG    WT     TG
**
WT TG
0.0
0.5
1.0
1.5
pA
kt
T3
08
/A
kt
 (A
.U
.)
pAktT308
Akt
WT   TG    WT     TG
WT TG
0.0
0.5
1.0
1.5
pA
kt
S4
73
/A
kt
 (A
.U
.)
pAktS473
Akt
WT   TG    WT     TG
0.0
0.5
1.0
1.5
WT   TG   WT   TG WT   TG   WT    TG
Ponceau S Anti-Puromycin
250
150
75
100
50
37
25
15
kDa
WT TG
0.0
0.5
1.0
1.5
ED
L 
pu
ro
m
yc
in
WT TG
0.0
0.5
1.0
1.5
SO
L 
pu
ro
m
yc
in
*
A B C
D E F
G
 52 
 
Figure 3.3 Effects of TRB3 knockout on protein synthesis and muscle mass. Ten- to 
eleven-week-old female wild type (WT) and whole-body TRB3 knockout (TRB3KO) 
mice were euthanized and GAS muscles were collected for analyses. (A-D) The levels of 
phosphorylation of signaling molecules, including mTOR (A), S6K (B), and Akt (C and 
D) were determined by Western blot. (E) Equally amount of protein lysates was analyzed 
for puromycin incorporation from SOL muscle. (F-G) The amount of puromycin 
incursion was determined in EDL (F) and SOL (G) muscles. (H-I) Muscle weights in 
TRB3KO mice were determined for TA (H) and GAS (I) muscles. Data are the means ± 
S.E.M. (n = 5-6 per group). * P < 0.05 vs. WT 
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Figure 3.4 Effects of TRB3 in skeletal muscle on protein degradation signaling and 
E3 ubiquitin ligases. (A-B) Phosphorylated FOXO1 (A) and 3a (B) were measured in 
GAS muscles from wild type (WT) and TRB3TG (TG) mice. (C) The mRNA expression 
of atrogin-1, MuRF-1, and cathepsin L was determined in TA muscle. (D-E) The levels 
of phosphorylation of FOXO1 (D) and 3a (E) were measured in GAS muscles from WT 
and TRB3KO (KO) mice. (F) Atrogin-1, MuRF-1, and cathepsin L mRNA expressions 
were determined in TA muscle. Data are the means ± S.E.M. (n = 5-6 per group). * P < 
0.05, ** P < 0.01 vs. WT
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CHAPTER 4 
TRB3 REGULATES SKELETAL MUSCLE MASS IN FOOD DEPRIVATION-
INDUCED ATROPHY1
                                                             
1 Choi RH, McConahay A, Silvestre JG, Moriscot AS, Carson JA, Koh HJ. 2019. The FASEB Journal. 33. 
Reprinted here with permission of publisher. 
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4.1 ABSTRACT 
Tribbles 3 (TRB3) is a pseudokinase that has been found in multiple tissues in 
response to various stress stimuli, such as nutrient deprivation and endoplasmic reticulum 
(ER) stress. We recently found that TRB3 has the potential to regulate skeletal muscle 
mass at the basal state. However, it has not yet been explored whether TRB3 regulates 
skeletal muscle mass under atrophic conditions. Here, we report that food deprivation for 
48 hr in mice significantly reduces muscle mass by ~15% and increases TRB3 
expression, which is associated with increased ER stress. Interestingly, inhibition of ER 
stress in C2C12 myotubes reduces food deprivation-induced expression of TRB3 and 
muscle specific E3-ubiquitin ligases. In further in vivo experiments, muscle-specific 
TRB3 transgenic mice increase food deprivation-induced muscle atrophy compared to 
WT littermates presumably by the increased proteolysis. On the other hand, TRB3 
knockout mice ameliorate food deprivation-induced atrophy compared to WT littermates 
by preserving a higher protein synthesis rate. These results indicate that TRB3 plays a 
pivotal role in skeletal muscle mass regulation under food deprivation-induced muscle 
atrophy and TRB3 could be a pharmaceutical target to prevent skeletal muscle atrophy.  
Key Words: protein synthesis, protein degradation, Akt, mTOR, FOXO 
 
4.2 INTRODUCTION 
Skeletal muscle is a highly malleable tissue, which can transform its 
characteristics depending on anabolic or catabolic stimuli. Anabolic signals, including 
insulin or insulin-like growth factor-1 (IGF-1), activate protein synthesis, leading to 
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muscle hypertrophy; whereas catabolic stimuli, such as energy imbalance and 
inflammation, activate protein degradation, resulting in muscle atrophy. These 
phenomena are important for regulation of skeletal muscle mass in order to maintain 
proper muscle function and strength for a population undergoing aging or diseases, 
including obesity, type 2 diabetes, and cancer.  
Muscle atrophy occurs in various pathophysiological conditions, such as 
starvation, inactivity, denervation, and sepsis, leading to poor quality of life among 
patients (Cohen, Nathan, & Goldberg, 2015). Multiple mechanisms can induce muscle 
wasting, including an imbalance between the rate of protein synthesis and breakdown 
(Schiaffino et al., 2013). The IGF-1/phosphoinositide 3 kinase (PI3K)/Akt pathway has 
been considered as a main mechanism to manage muscle protein homeostasis (Latres et 
al., 2005; Stitt et al., 2004). Phosphorylation/activation of Akt provokes protein synthesis 
through the activation of mechanistic target of rapamycin (mTOR) and inhibits protein 
breakdown via the phosphorylation of forkhead box O families (FOXOs) (Glass, 2005). 
Phosphorylation of mTOR mediates a subsequent phosphorylation of ribosomal S6 
kinase 1 (S6K1) and eukaryotic translation initiation factor 4E-binding protein 1 (4EBP1) 
to induce protein synthesis (Bodine, Stitt, et al., 2001; Gingras, Kennedy, O'Leary, 
Sonenberg, & Hay, 1998; Rommel et al., 2001). FOXOs, another downstream target of 
Akt, are transcription factors that induce transcription of the genes involved in protein 
degradation, including muscle-specific E3 ubiquitin ligases, muscle atrophy F-box 
(atrogin-1) and muscle RING finger-1 (MuRF-1) (Sandri et al., 2004; Waddell et al., 
2008). In addition to the activation of the ubiquitin-proteasome proteolysis system by 
FOXOs, dephosphorylation of FOXOs has been associated with the upregulation of 
autophagy-lysosomal protein degradation (Mammucari et al., 2007; Milan et al., 2015; 
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Zhao et al., 2007). These studies have established the idea that the regulation of Akt 
signaling is a significant target to control protein synthesis and degradation in skeletal 
muscle. However, the mechanism(s) that manages the activation of Akt to regulate 
skeletal muscle mass has not been fully described.  
Tribbles 3 (TRB3), a mammalian Drosophila tribbles homolog 3, is a 
pseudokinase which contains a kinase domain without catalytic function (Grosshans & 
Wieschaus, 2000). Its expression has been associated with several stress conditions, such 
as endoplasmic reticulum (ER) stress, insulin resistance, glucose toxicity, and 
tumorigenesis (Koh et al., 2013; J. Liu et al., 2010; Ohoka et al., 2005; Xu et al., 2007; 
Zhang et al., 2013). Functionally, TRB3 has been known as a negative regulator of Akt in 
metabolic tissues, including liver, fat, and skeletal muscle, through disrupting 
phosphorylation of Akt (Du et al., 2003; Koh et al., 2013). In skeletal muscle, increased 
TRB3 has been associated with insulin resistance. A study that utilized TRB3 knockout 
mice fed a high-fat diet found that the knockout mice had improved glucose tolerance and 
insulin-stimulated Akt activation, resulting in the prevention of high-fat diet-induced 
obesity (Koh et al., 2013). Previously, we found that TRB3 in mouse skeletal muscle 
plays a critical role in the regulation of protein turnover at the basal state using both 
muscle-specific TRB3 transgenic (TG) and whole-body TRB3 knockout (KO) mice. TG 
mice had an inhibited protein synthesis rate confirmed by decreased phosphorylation of 
mTOR and S6K1 and puromycin incorporation, while the KO mice had an enhanced 
protein synthesis rate in soleus muscle (R. H. Choi et al., 2017). TG mice also showed an 
increase in the protein degradation pathway, evidenced by upregulation of atrogin-1 and 
MuRF-1, whereas KO mice had a decreased expression of atrogin-1 and MuRF-1 (R. H. 
Choi et al., 2017). Although skeletal muscle TRB3 has the potential to regulate skeletal 
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muscle mass at basal levels, the effect of TRB3 on skeletal muscle mass regulation under 
atrophic conditions has not yet been defined.  
Atrophic conditions, such as starvation and denervation, can prompt ER stress and 
the unfolded protein response (UPR) (Paul et al., 2012; Yu et al., 2011). These processes 
have been associated with the regulation of skeletal muscle mass and function (Bohnert, 
McMillan, & Kumar, 2018), however the mechanism(s) is not completely understood. 
TRB3 interacts with activating transcription factor 4 (ATF4) and C/EBP homologous 
protein (CHOP), which are ER stress markers, under ER stress conditions and nutrient 
deprivation conditions (Jousse et al., 2007; Ohoka et al., 2005; Ord & Ord, 2003). 
Moreover, TRB3 has been known to respond to ER stress in skeletal muscle (Koh et al., 
2013). The activation of ER stress via ER stress inducers, such as tunicamycin or 
thapsigargin, increases TRB3 expression (Koh et al., 2013; Ohoka et al., 2005; Ord & 
Ord, 2005). The ER stress-induced TRB3 has been related to the activation of ATF4 and 
CHOP, which is an important arm among three UPR pathways to regulate global 
translation (Jousse et al., 2007; Ohoka et al., 2005; Ord & Ord, 2005; Walter & Ron, 
2011). Although a direct mechanism(s) of stress-induced TRB3 expression in skeletal 
muscle has not been revealed, based on previous findings, it is promising that ER stress 
could upregulate TRB3 expression in response to food deprivation. Therefore, in this 
study, we withdrew food to induce muscle atrophy. In addition to the protein turnover, 
we also investigated whether food deprivation-induced ER stress mediates TRB3 
expression.  
Here we show that 48 hr food deprivation increased TRB3 expression in mouse 
skeletal muscle and blunted the phosphorylation of Akt and its downstream signaling 
molecules, resulting in an upregulation of muscle-specific E3 ubiquitin ligases. 
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Furthermore, food deprivation induced ER stress markers in vivo and in vitro. Blocking 
of ER stress using 4-phenylbutric acid attenuated ER stress and TRB3 expression in 
C2C12 cells after 6 hr of PBS-induced starvation. TG mice had significantly higher levels 
of food deprivation-induced muscle atrophy along with greater activation of FOXOs and 
atrogenes. In contrast, the knockout of TRB3 prevented mice from food deprivation-
induced atrophy, resulting from maintenance of protein synthesis rate after 48 hr 
starvation with higher activation of the protein synthesis pathway. Therefore, our study 
reveals that TRB3 plays an important role in food deprivation-induced skeletal muscle 
atrophy and may be a potentials target strategy for the maintenance of skeletal muscle 
mass during atrophic conditions.  
 
4.3 MATERIALS AND METHODS  
Animal care and food deprivation procedure 
Ten- to thirteen-week-old C57BL/6 wild type, muscle-specific TRB3 transgenic 
(TG), and whole-body TRB3 knockout (KO) mice were used for the current study. All 
animals were maintained in the animal facility at the University of South Carolina and 
were housed in an environmentally controlled room on a 12 hr light-dark cycle. During 
the 48 hr food deprivation experiment, standard chow diet (Harlan Teklad Diet, 
Madision, WI, USA) was removed from the food deprivation group with ad libitum 
access to water. For the fed group, mice had free access to food and water. All protocols 
were approved by the Institutional Animal Care and Use Committee of the University of 
South Carolina.  
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Cell culture  
C2C12 myoblasts were grown in Dulbecco’s modified Eagle’s medium (DMEM) 
containing 10% fetal bovine serum. When the cells reached ~ 90 % of confluence, 
differentiation was induced by replacing the growth media with media containing 2% 
horse serum for 4 days as described previously (Koh et al., 2013). For cell starvation 
experiments, myotubes were incubated in sterile phosphate-buffered saline (PBS) for 6 
hr. To block ER stress during cell starvation, additional myotubes were pre-incubated 
with 5 mM of 4-phenylbutric acid (4-PBA) (P21005; Sigma, St. Louis, MO) 30 min prior 
to PBS starvation. Cells were then starved in PBS in the presence of 4-PBA for 6 hr. 
Protein extraction and western blot analysis 
Frozen tibialis anterior (TA) muscles were grinded by a homogenizer (Next 
Advandce, Inc., Troy, NY, USA) and lysed in a buffer containing 20 mM Tris-HCl 
pH7.4, 5 mM EDTA, 10 mM Na3PO4, 100 mM NaF, 2 mM Na3VO4, 1% NP-40, and 
HaltTM Protease and Phosphatase Inhibitor Single-Use Cocktail. To collect proteins from 
C2C12 myotubes, media from each well was removed and washed twice with ice-cold 
PBS. Then, the lysis buffer was added and the myotubes were scrapped by using a sterile 
cell scrapper. Tissue and cell lysates (30 – 60 mg) were separated by 15 – 8% SDS-
PAGE and transferred to PVDF membrane. The membranes were incubated in 5% 
bovine serum albumin blocking buffer for 1 h then primary antibodies were applied for 
overnight incubation at 4 ºC. Blots were washed three times for 10 min each with TBST, 
then incubated with a specific secondary antibody (1:2000 – 5000). Blots were visualized 
with chemiluminescent substrates (PerkinElmer, Waltham, MA, USA) and quantified by 
Image Studio Lite (LI-COR Biosciences, Lincoln, NE, USA). All primary and secondary 
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antibodies used in this study were commercially available, including pAktT308 (#9275), 
Akt (#9271), pmTORS2448 (#2971), mTOR (#2972), pFOXO1S256 (#9461), FOXO1 
(#2880), pFOXO3aS253 (#13129), FOXO3a (#12829), GAPDH (#2118) from Cell 
Signaling Technology (Danvers, MA, USA), atrogin-1 (AP2041), MuRF-1 (MP3401) 
from ECM (Versailles, KY, USA), TRB3 (ST1032; Calbiochem, San Diego, CA, USA), 
anti-puromycin (MABE343; ECM Millipore, Billerica, MA, USA), horseradish 
peroxidase-lined anti-rabbit secondary antibody (NA934; GE healthcare, Pittsburgh, PA, 
USA), and IgG2a-horseradish peroxidase conjugate anti-mouse secondary antibody (61-
0220; Invitrogen, Carlsbad, CA, USA).  
RNA extraction and real-time polymerase chain reaction 
Total RNA was extracted from TA muscles and C2C12 myotubes using a Trizol 
reagent (Life Technologies, Carlsbad, CA, USA) according to the manufacturer’s 
instructions. cDNA was synthesized from 4 µg of total RNA with the High Capacity 
cDNA kit (Life Technologies, Carlsbad, CA, USA). cDNA and primers for real-time 
polymerase chain reaction (RT-PCR) were carried by SYBR green PCR master mix (Life 
Technologies, Carlsbad, CA, USA). Primer sequences are as shown in Table 1. All genes 
were normalized to the level of TBP for in vivo tissues and the level of 18S for in vitro 
samples. 
In vivo protein synthesis measurement  
In vivo protein synthesis rate was measured with a nonradioactive technique using 
puromycin incorporation into a nascent peptide as previously described (Goodman et al., 
2011). Briefly, mice were given an intraperitoneal injection of 0.04 µmol/g puromycin 
(EDM Millipore, Billerica, MA, USA) dissolved in 100 µl of PBS 30 min before 
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euthanasia. After 30 min of the injection, tissues were collected and frozen immediately 
in liquid nitrogen then stored at – 80 ºC until the analysis. Details of puromycin 
immunoblotting can be found in the Protein extraction and western blot analysis section.  
Statistical analysis  
All results are presented as mean ± SEM. Statistical analysis was performed using 
GraphPad Prism 7 (La Jolla, CA, USA). Student’s two-tailed unpaired t tests were used 
for comparisons between two groups. One- or two-way ANOVA was conducted to 
determine significance between more than two group followed by Tukey’s or Sidak Post 
hoc analysis. P < 0.05 was considered statistically significant.  
 
4.4 RESULTS 
48 hr food deprivation increases TRB3 expression in mouse skeletal muscle 
To determine the role of TRB3 in food deprivation-induced muscle atrophy, we 
first determined TRB3 expression in response to 48 hr food deprivation. C57BL/6 wild-
type mice were divided into two groups. One group freely consumed standard chow diet 
(Fed) while the other group was withdrawn food for 48 hr. Water was accessible ad 
libitum for both groups. After 48 hr, body weight was measured before euthanasia. Mice 
that had undergone 48 hr food deprivation had significantly decreased body weight more 
than 20% compared to Fed controls (Fig. 4.1A). Consistently, multiple skeletal muscles, 
including tibialis anterior (TA), extensor digitorum longus (EDL), soleus (SOL), and 
gastrocnemius (GAS), from the food deprivation group showed a 15% decrease in muscle 
weight compared to those from Fed (Fig. 4.1B). There was no significant difference in 
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the percentage of muscle atrophy among four muscles after 48 hr of food deprivation. 
Our method, food deprivation for 48 hr, was sufficient to induce skeletal muscle atrophy 
in mice. Interestingly, 48 hr food deprivation significantly increased TRB3 mRNA and 
protein expression in mouse skeletal muscle by 300% and 30%, respectively (Fig. 4.1C 
and D). These data demonstrate that food deprivation for 48 hr induces skeletal muscle 
atrophy and increases TRB3 expression in mouse skeletal muscle. 
48 hr food deprivation inhibits Akt phosphorylation and activates protein degradation 
Muscle wasting is regulated by the balance between protein synthesis and protein 
degradation (Schiaffino et al., 2013). The IGF-1/PI3K/Akt pathway is critical for the 
control of protein turnover through mTOR and FOXOs signaling (Latres et al., 2005; Stitt 
et al., 2004). Since our method was sufficient to decrease muscle mass (Fig. 4.1B), we 
next examined if Akt and FOXOs are involved in food deprivation-induced skeletal 
muscle atrophy. After 48 hr food deprivation, phosphorylation of Akt at Thr308 in the 
food deprivation group was significantly decreased compared to the Fed group (Fig. 
4.1E). Phosphorylation of Akt at Ser473 did not respond to 48 hr food deprivation 
(Supplementary Fig. S4.1A). Further, phosphorylation of FOXO1 and FOXO3a was 
dramatically decreased in the food deprivation group, suggesting the activation of 
FOXOs (Fig. 4.1F and G). Dephosphorylated FOXOs are required for upregulation of 
atrogin-1 and MuRF-1, skeletal muscle-specific E3 ubiquitin ligases (Sacheck et al., 
2004; Sandri et al., 2004; Waddell et al., 2008). In line with this, we also found that 48 hr 
food deprivation significantly increased atrogin-1 and MuRF-1 mRNA expression in 
mouse skeletal muscle (Fig. 4.1H). Together, these results demonstrate that 48 hr food 
deprivation inhibits Akt signaling but activates FOXOs and muscle-specific E3 ubiquitin 
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ligases, which may be responsible for 48 hr food deprivation-induced skeletal muscle 
atrophy. 
Food deprivation induces ER stress in vivo and in vitro and ER stress meditates food 
deprivation-induced TRB3 expression 
 It has been previously determined that TRB3 interacts with ATF4 and CHOP, 
which are ER stress markers and one of the UPR pathways, and coordinates ATF4-
related apoptosis during ER stress (Jousse et al., 2007; Ohoka et al., 2005; Ord & Ord, 
2003). Therefore, we next hypothesized that food deprivation-induced TRB3 expression 
is mediated by increased ER stress. We first analyzed ER stress markers in skeletal 
muscles from food deprived wild-type mice. The expression of ATF4 and XBP1 was 
significantly increased in skeletal muscles from the food deprivation group (Fig. 4.2A). 
The mRNA expression of ATF6 and GRP78 tended to be higher in response to food 
deprivation (Fig. 4.2A). To further determine if ER stress triggers the upregulation of 
TRB3 in response to food deprivation, we incubated C2C12 myotubes with PBS, which 
can mimic food deprivation-induced muscle atrophy (Paul et al., 2012; Sandri et al., 
2004). After 6 hr of PBS incubation, the expression of ER stress markers, including 
ATF4, CHOP, XBP1, and GPR78/Bip, and atrogin-1 was robustly elevated (Fig. 4.2B). 
Interestingly, TRB3 mRNA expression was also increased by more than 2.6-fold (Fig. 
4.2B). To test if ER stress is required to increase TRB3 expression in response to food 
deprivation, C2C12 myotubes were treated with 4-PBA, an ER stress blocker, and TRB3 
and ER stress markers were determined. The 4-PBA treatment significantly blunted ER 
stress responses in starved cells (Fig. 4.2B). Interestingly, PBS incubated C2C12 
myotubes with 4-PBA treatment had significantly reduced expression of TRB3 and 
muscle-specific E3 ubiquitin ligases (Fig. 4.2B). These data suggest that ER stress is 
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necessary to induce TRB3 expression in response to food deprivation and TRB3 may 
play a regulatory role in the expression of atrogenes.  
Overexpression of TRB3 aggravates food deprivation-induced skeletal muscle atrophy 
To further determine the effect of TRB3 in skeletal muscle atrophy, we used a 
muscle-specific TRB3 transgenic (TG) mouse model (Fig. 4.3A). In our previous studies, 
we found that TG mice displayed smaller muscle weight and cross-sectional area with 
suppressed protein synthesis and accelerated protein degradation compared to wild-type 
(WT) littermates at the basal state (R. H. Choi et al., 2017). Therefore, we hypothesized 
that TG mice are more prone to food deprivation-induced atrophy compared to WT. WT 
and TG mice were undergone food deprivation for 48 hr and body weight was measured. 
Forty-eight hours of food deprivation significantly decreased body weight in both WT 
and TG mice and there was no difference between genotypes (Fig. 4.3B). Interestingly, 
TG mice had markedly increased muscle atrophy by ~22% in various muscles compared 
to wild type (Fig. 4.3C). These findings suggest that overexpression of TRB3 in skeletal 
muscle exacerbates skeletal muscle atrophy in response to 48 hr food deprivation. 
TRB3 overexpression activates FOXOs and ubiquitin-proteasome proteolysis 
Based on our data indicating that overexpression of TRB3 aggravated food 
deprivation-induced muscle atrophy (Fig. 4.3C), we next investigated whether muscle-
specific TRB3 overexpression may influence the Akt-FOXOs-ubiquitin-proteasome 
protein degradation pathway. The phosphorylation of Akt (Thr308) and subsequently 
FOXO1 (S256) phosphorylation was significantly diminished after 48 hr food deprivation 
(Fig. 4.4A and B), whereas Akt phosphorylation at Ser 473 was not altered 
(Supplementary Fig. S4.1B). Additionally, there was a trend for activation and 
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dephosphorylation of FOXO3a in WT after 48 hr food deprivation, whereas TG mice had 
significantly activated FOXO3a (Fig. 4.4C). In agreement with increased FOXOs 
activation, atrogin-1 and MuRF-1 mRNA expression was highly elevated independently 
of genotype (Fig. 4.4D). In protein expression, however, TG mice displayed a greater 
increase in atrogin-1 and MuRF-1 after 48 hr food deprivation compared to WT (Fig. 
4.4E and F). These data suggest that TRB3 may accelerate the ubiquitin-proteasome 
proteolysis system. 
It has been well established that autophagy plays an important role in skeletal 
muscle mass regulation under atrophic conditions (Mammucari et al., 2007; Ogata, Oishi, 
Higuchi, & Muraoka, 2010). To determine the effect of TRB3 on food deprivation-
induced autophagy, we measured autophagic markers, including polyubiquitin-binding 
protein (p62) and microtubule-associated protein 1 light chain-3B (LC3B), which have 
been previously reported to increase in skeletal muscle in response to food deprivation 
(Mammucari et al., 2007; Paul et al., 2012). Recently, it has been demonstrated that 
TRB3 interacts with p62 to induce an accumulation in the human branchial epithelial cell 
line (Hua et al., 2015). In our current study, 48 hr food deprivation greatly increased p62 
in both genotypes, but TG mice displayed a further increase in p62 protein expression 
(Fig. 4.4G). In addition to p62, conversion of LC3B-I to LC3B-II is a critical marker of 
autophagosome formation (Levine & Kroemer, 2008). We measured LC3B by Western 
blot and found that 48 hr food withdrawal dramatically increased LC3B conversion in 
both genotypes with a trend to be higher in TG mice (Fig. 4.4H). These results suggest 
that TRB3 plays a role in the upregulation of food deprivation-induced autophagy.  
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Muscle-specific TRB3 overexpression does not augment the effect of food deprivation 
on protein synthesis rate and signaling pathway 
Loss of muscle mass is stimulated by not only increased protein degradation, but 
also decreased protein synthesis (Schiaffino et al., 2013). Our previous study has reported 
that TRB3 overexpression in mouse skeletal muscle results in a decrease in protein 
synthesis rate at the basal condition (R. H. Choi et al., 2017). In our current study, we 
observed that TRB3 overexpression in mouse skeletal muscle promoted atrogin-1 and 
MuRF-1 expression after 48 hr food deprivation compared to WT (Fig. 4.4E and F). 
Therefore, we further determined whether TRB3 overexpression would have an effect on 
Akt downstream molecules related to protein synthesis under atrophic conditions. Forty-
eight hours of food deprivation decreased the protein synthesis rate by 60 – 65% in WT 
(Fig. 4.5A and B). Consistent with our previous study (R. H. Choi et al., 2017), 
overexpression of TRB3 decreased protein synthesis rate at fed state (Fig. 4.5A and B). 
Although TG mice showed significantly suppressed protein synthesis rate in fed state, TG 
mice had no further effect on protein synthesis rate in response to 48 hr food derivation 
(Fig. 4.5B). There was no significant difference in protein synthesis rate between 
genotypes after 48 hr food deprivation. Next, we determined the effect of TRB3 on 
signaling molecules related to protein synthesis. Forty-eight hours of food withdrawal did 
not affect mTOR phosphorylation in either genotype (Fig. 4.5C). Although a statistical 
significance was not found, phosphorylation of mTOR in TG mice at the basal state was 
50% less than WT (Fig. 4.5C). To understand what factors may influence the decreased 
protein synthesis rate in TG mice, we examined the proteins upstream and downstream of 
mTOR, including PRAS40, TSC2, and 4EBP1. Forty-eight hours of food deprivation 
resulted in a significant increase in dephosphorylation of 4EBP1 (S65) in both genotypes, 
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suggesting diminished initiation of protein synthesis (Fig. 4.5D). It is known that Akt 
regulates mTOR activity by phosphorylating PRAS40 and TSC2 (Inoki et al., 2002; 
Vander Haar et al., 2007). Therefore, we tested both signaling molecules to evaluate 
whether TRB3 affects them to regulate mTOR activity. Phosphorylated PRAS40 (T246) 
was significantly decreased only in TG mice after 48 hr food deprivation (Fig. 4.5E). 
Phosphorylation of TSC2 (T1462) was significantly decreased in TG mice at fed state 
like mTOR (Fig. 4.5F). Forty-eight hours of food deprivation decreased TSC2 
phosphorylation in both WT and TG mice, and there was no difference in TSC2 
phosphorylation between genotypes (Fig. 4.5F). These data support the result that TG 
mice showed the decreased protein synthesis rate under fed condition but did not 
augment the rate in response to 48 hr food deprivation. Taken together, these findings 
demonstrate that the worsening food deprivation-induced skeletal muscle atrophy in TG 
mice is not due to the change in protein synthesis rate. 
TRB3 knockout prevents 48 hr food deprivation-induced muscle atrophy 
We found that TRB3 overexpression in mouse skeletal muscle notably decreased 
muscle mass in response to 48 hr food deprivation (Fig. 4.3C). This augmented muscle 
atrophy in TG mice could result more likely from an increased expression of muscle-
specific E3 ubiquitin ligases (Fig. 4.4E and F) but less likely from protein synthesis rate 
and activity of signaling molecules (Fig. 4.5A – F). To determine whether TRB3 has the 
potential to be a pharmaceutical target to ameliorate skeletal muscle wasting, we next 
examined TRB3 knockout (KO) mice with the 48 hr food deprivation We first confirmed 
that KO mice expressed significantly lower amount of TRB3 in TA muscle compared to 
WT littermates (Fig. 4.6A). Next, WT and KO mice underwent 48 hr food deprivation, 
and displayed reduced body weight more than 20 % after food withdrawal (Fig. 4.6B). 
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Intriguingly, we observed a smaller degree of muscle wasting in some muscles from KO 
mice compared to WT (Fig. 4.6C). These findings indicate that the knockout of TRB3 in 
skeletal muscle prevents food deprivation-induced muscle atrophy.  
TRB3 knockout blunts a reduction of protein synthesis after 48 hr food deprivation 
The preventive effect of TRB3 knockout on food deprivation-induced muscle loss 
may be associated with increased protein synthesis based on our previous report (R. H. 
Choi et al., 2017). To examine the mechanism(s) by which knockout of TRB3 prevented 
food deprivation-induced muscle atrophy, we measured the protein synthesis rate and 
signaling pathway in TA muscle. As previously shown, protein synthesis rate was 
dramatically reduced after 48 hr food withdrawal in both WT and KO mice (Fig. 4.7A 
and B). However, the knockout of TRB3 ameliorated the food deprivation-induced 
reduction in the protein synthesis rate (Fig. 4.7B). This phenomenon could promote 
maintenance of muscle mass in KO mice and protect the KO mice from food deprivation-
induced atrophy compared to WT. Next, we examined signaling molecules involved in 
protein synthesis, including mTOR, 4EBP1, PRAS40 and TSC2. However, there was no 
significant differences between genotypes (Fig. 4.7C – F). The same results were 
observed in EDL muscle (Supplementary Fig. S4.2 and S4.3). This may be due to a flaw 
in our methodology. We may not be able to capture the correct time point for detection of 
alterations in signaling pathways since we sacrifice mice 30 min after puromycin 
injection. On the basis of the increased protein synthesis rate in KO mice, there is the 
possibility that the protein synthesis pathway may be affected by genotype. These data 
suggest that increased muscle mass in KO mice could be due to preserving protein 
synthesis rate.  
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4.5 DISCUSSION 
TRB3 has been known as a negative regulator of the insulin signaling pathway 
focused on Akt phosphorylation (Du et al., 2003; Koh et al., 2006). Its expression is 
involved in pathophysiology of multiple diseases, including diabetes and obesity, 
resulting in insulin resistance (Koh et al., 2013; Zhang et al., 2013). Recently, we 
demonstrated that the overexpression of TRB3 in mouse skeletal muscle decreases 
protein synthesis and increases protein degradation through the disruption of Akt and its 
downstream molecules at the basal state (R. H. Choi et al., 2017). However, it has not yet 
been elucidated whether TRB3 affects skeletal muscle mass regulation under atrophic 
conditions. Therefore, in this study we examined the role of TRB3 in the regulation of 
skeletal muscle mass under 48 hr food deprivation-induced skeletal muscle atrophy. 
This study demonstrated that TRB3 mRNA and protein expressions were 
significantly elevated in mouse skeletal muscle after 48 hr food deprivation (Fig. 4.1C 
and D). Previously, it has been established that food deprivation for 24 hr can induce 
TRB3 expression in liver and fat (Du et al., 2003; Qi et al., 2006). Our data is the first 
report showing that 48 hr food deprivation is sufficient to induce TRB3 expression in 
mouse skeletal muscle (Fig. 4.1C and D). In addition, our study and others demonstrated 
that an incremental increase of TRB3 expression in multiple tissues impairs the insulin-
stimulated Akt (Avery et al., 2010; Koh et al., 2013). Here, we showed that 48 hr food 
deprivation significantly reduced skeletal muscle mass along with a decrease in 
phosphorylation of Akt and FOXOs, leading to upregulation of atrogin-1 and MuRF-1 
(Fig. 4.2A - D). Taken together, food deprivation-induced TRB3 expression in mouse 
skeletal muscle may decrease Akt phosphorylation and activate FOXOs and muscle-
specific E3 ubiquitin ligases.   
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A significant reduction in the phosphorylation of Akt in response to food 
withdrawal (Fig. 4.2A) has been observed in other studies (Paul et al., 2012; Sandri et al., 
2004). Blunted Akt phosphorylation subsequently leads to the dephosphorylation of 
FOXO1 and 3a, which translocate to the nucleus to promote the transcriptions of protein 
degradation genes, such as atrogin-1 and MuRF-1 (Sandri et al., 2004; Stitt et al., 2004). 
In line with this, we observed that 48 hr food deprivation significantly reduced the 
phosphorylation of FOXO1, but not of FOXO3a (Fig. 4.1F and G), leading to increased 
muscle-specific E3 ubiquitin ligases (Fig. 4.1H). This phenomenon has previously been 
observed (Ogata et al., 2010) and there has been evidence that different isoforms of 
FOXOs can coordinately assist their activation (Sandri et al., 2004).  
Our finding that ER stress mediates TRB3 and atrogenes expression in response 
to starvation suggest that ER stress is an important regulator of TRB3 expression in 
skeletal muscle (Fig. 4.2B). Although earlier studies have shown a tight relationship 
between ER stress and TRB3 in regulatory mechanisms, it has not been determined in 
skeletal muscle and food deprivation conditions. For example, tunicamycin treated 
HepG2 cells have an increase in TRB3 expression following an elevation of ATF4 and 
CHOP (Ohoka et al., 2005), whereas ER stress-induced TRB3 expression is completely 
blocked in ATF4 knockdown mouse embryonic fibroblasts (Jousse et al., 2007). While 
these studies suggest that ER stress may play a critical role in TRB3 expression, our 
results indicate that ER stress may be required to induce TRB3 expression in skeletal 
muscle under food deprivation conditions. Furthermore, our data suggest that food 
deprivation-induced atrophy may be mediated by ER stress-induced TRB3 expression. In 
the current experiment, however, we could not determine if TRB3 is required for food 
deprivation-induced and/or ER stress-mediated atrophy. To examine a precise 
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mechanism, it will be necessary to utilize TRB3 knockdown in C2C12 cells or isolated 
primary cells from skeletal muscle of KO mice to demonstrate if food deprivation-
induced atrophy is prevented in the absence of TRB3. These experiments will be 
performed in our future studies. 
In this study, we demonstrated that muscle-specific TRB3 overexpression resulted 
in increased 48 hr food deprivation-induced muscle atrophy compared to WT (Fig. 4.3C). 
Previously, we have reported that TG mice present smaller muscle weights and a reduced 
rate of protein synthesis compare to WT at the basal condition (R. H. Choi et al., 2017). 
Our previous and current studies consistently demonstrate that muscle-specific TRB3 
overexpression significantly increased atrogin-1 and MuRF-1 at basal and under food 
deprivation-induced atrophic conditions (Fig. 4.4E and F) (R. H. Choi et al., 2017). In 
contrast, An et al. reported that the same mice display larger muscle mass in SOL and 
GAS compared to WT littermates (An et al., 2014). This may be due to differences in the 
number of TG mice backcrossing and diet as previously reported (R. H. Choi et al., 
2017). Although the reason for the discrepancy is not clear, our current results were 
consistent with our previous study. Therefore, based on our findings, TRB3 may have the 
potential to be a critical regulator of skeletal muscle mass at basal and also under food 
deprivation-induced atrophy conditions. 
Given that TRB3 impairs Akt signaling in skeletal muscle and other tissues (Du et 
al., 2003; Koh et al., 2013; Zhang et al., 2016), we anticipated the decreased Akt 
phosphorylation in TG mice after 48 hr food deprivation. However, we did not observe 
any differences in Akt phosphorylation between WT and TG mice. The discrepancy is 
likely due to the different experimental settings. Our previous study and others have 
examined Akt phosphorylation after insulin stimulation (Du et al., 2003; Koh et al., 2013; 
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Zhang et al., 2016). In our current study, we measured the basal level of Akt 
phosphorylation in order to precisely determine the role of TRB3 in food deprivation-
induced skeletal muscle atrophy since insulin can initiate anabolic signaling pathways to 
alter protein turnover (Schiaffino et al., 2013). Although we did not detect differences in 
Akt phosphorylation between genotypes, our data demonstrate that TRB3 overexpression 
in skeletal muscle could affect Akt-downstream proteins associated with protein turnover. 
For future studies, it will be important to determine Akt phosphorylation in insulin-
stimulated condition. In addition, more sensitive methodology to detect definite changes 
in Akt activity will be necessary, such as Akt kinase assay. 
In addition to upregulating the ubiquitin-proteasome system in response to food 
withdrawal, autophagy-lysosomal protein degradation is activated under atrophic 
conditions (Mammucari et al., 2007; Paul et al., 2012). In this study, TG mice displayed 
significantly increased p62 accumulation compared to WT (Fig. 4.4G). Recently, it has 
been reported that the overexpression of TRB3 in human bronchial epithelial cells and 
diabetic mice results in the accumulation of p62 (Hua et al., 2015). Although the current 
and previous findings have been confirmed in different tissues and experimental 
conditions, TRB3 expression seems to play an essential role in the autophagic process. 
The activation of FOXOs has been considered as an important regulator of not only 
ubiquitin-proteasome proteolysis (Sandri et al., 2004; Waddell et al., 2008) but also 
autophagy-lysosomal protein degradation (Mammucari et al., 2007; Milan et al., 2015; 
Zhao et al., 2007). However, TG mice did not show any differences in FOXO1 and 
FOXO3a activation in response to food deprivation compared to WT (Fig. 4.4B and C). 
These results represent only a small piece of the process. Although we could not find any 
differences in the activation of FOXOs between WT and TG mice in response to food 
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deprivation, we cannot fully exclude the possibility that the overexpression of TRB3 may 
affect the activation of FOXOs to induce ubiquitin-proteasome and autophagy-lysosomal 
protein degradations.  
Along with protein degradation, skeletal muscle mass is also regulated by protein 
synthesis. Forty-eight hours of food deprivation diminished protein synthesis rate by 
more than 60% in WT mice (Fig. 4.5A – B). In accordance with our previous study (R. 
H. Choi et al., 2017), TG mice showed significantly suppressed protein synthesis rate at 
fed state (Fig. 4.5B). However, we did not detect further reduction in protein synthesis 
rate in TG mice after 48 hr food deprivation. This may be due to the fact that the level of 
protein synthesis was already decreased in TG mice in fed state (60 % of fed WT mice) 
and no further decrease could be made by 48 hr food deprivation. To determine how 
TRB3 overexpression hinders protein synthesis, we further investigated expression of 
signaling molecules related to mTOR regulation, such as 4EBP1, PRAS40, and TSC2. 
TRB3 overexpression in mouse skeletal muscle significantly reduced the phosphorylation 
of PRAS40 and TSC2 during food deprivation and at fed conditions, respectively (Fig. 
4.5E and F). Both PRAS40 and TSC2 are known to be negative regulators of mTOR and 
are inhibited by Akt phosphorylation (Inoki et al., 2002; Vander Haar et al., 2007). In line 
with our results, TRB3 overexpression in primary mouse hepatocytes has been shown to 
downregulate Akt-TSC2-mTOR pathway and activate 4EBP1, resulting in an inhibition 
of nutrient- and insulin-induced S6K1 activity (Matsushima et al., 2006). These findings 
suggest that TRB3 plays a critical role in the regulation of not only the Akt but also Akt-
associated proteins, including PRAS40 and TSC2. Taken together, our data indicates that 
the worsening skeletal muscle atrophy in response to 48 hr food deprivation may be due 
to the increased proteolysis pathways rather than changing protein synthesis rate.  
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We utilized our whole-body TRB3 knockout mouse model to determine the role 
of TRB3 in skeletal muscle mass regulation under atrophic conditions. We collected 
multiple hindlimb muscles and measured their weights to study whether there were 
variations of food deprivation-induced muscle atrophy in a muscle fiber-type specific 
manner. In contrast to TG mice, the knockout of TRB3 protected mice from food 
deprivation-induced muscle atrophy, especially in TA and EDL (Fig. 4.6C). This 
variation may be caused by various compositions of muscle fiber-type in specific 
muscles. For instance, TA and EDL contains more fast-glycolytic type IIb fiber than 
SOL, which mainly contains slow-oxidative type I and fast-oxidative type IIa 
(Kammoun, Cassar-Malek, Meunier, & Picard, 2014). In addition, it has been revealed 
that food deprivation could preferentially affect protein turnover in fast-glycolytic fibers 
(Ciciliot, Rossi, Dyar, Blaauw, & Schiaffino, 2013; Li & Goldberg, 1976). Based on our 
previous study, KO mice have larger muscle mass and higher protein synthesis rate 
compared to WT mice (R. H. Choi et al., 2017). Therefore, we measured the protein 
synthesis rate in the skeletal muscle from food deprived mice to examine whether KO 
mice can maintain a higher protein synthesis rate. Puromycin incorporation was highly 
preserved in KO mice compared to WT after 48 hr food deprivation (Fig. 4.7B). This 
may support the result that food deprivation-induced muscle atrophy was inhibited in KO 
mice. However, in this study, we did not find any differences in the expression of 
signaling molecules related to protein synthesis pathways (Fig. 4.7C – F). Furthermore, 
there were no differences in protein degradation pathways, including FOXO1 and 3a, and 
atrogenes expression (data not shown). It is possible that changes in signaling activities at 
the molecular level may have already occurred prior to the sacrifice, which occurred 30 
min after puromycin injection. In addition, unlike TG mice, the KO mice were a global 
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knockout, meaning that TRB3 expression is downregulated in a whole-body manner. 
Therefore, it is difficult to observe muscle-specific roles of TRB3 in the regulation of 
skeletal muscle mass under food deprivation conditions. Nonetheless, our data suggest a 
possibility that TRB3 has the potential to be a therapeutic target for skeletal muscle 
atrophy.  
In summary, 48 hr food deprivation induced the expression of TRB3 in skeletal 
muscle and resulted in muscle atrophy. ER stress was required to induce TRB3 
expression in response to food deprivation. Overexpression of TRB3 in mouse skeletal 
muscle increased food deprivation-induced atrophy via activating ubiquitin-proteasomal 
and autophagy-lysosomal protein degradation. TRB3 knockout mice were protected from 
food deprivation-induced atrophy via the maintenance of proteins synthesis rate. We 
conclude that TRB3 plays a pivotal role in food deprivation-induced skeletal muscle 
atrophy. Our data also suggest that TRB3 may be a potential target for maintaining 
skeletal muscle mass under food deprivation-induced atrophic condition. 
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Table 4.1 Primer sequences for RT-PCR 
 
TBP, TATA-box binding protein; ATF4, activating transcription factor 4; CHOP, C/EBP 
homologous protein; ATF6, activating transcription factor 6; XBP1s, spliced X-box 
binding protein 1, XBP1t, total X-box binding protein 1; GRP78, 78 kDa glucose-
regulated protein; eIF2α, eukaryotic translation initiation factor 2α 
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Figure 4.1 Food deprivation increases TRB3 expression and decreases Akt and 
FOXOs phosphorylation. Ten- to thirteen-week-old female C57BL/6 wild-type mice 
underwent either free access to food (Fed) or food deprivation (FD) for 48 hr. Body 
weight was measured before and after the procedure. (A) Percentage difference in body 
weight before and after 48 hr of each treatment was calculated. (B) Percentage of skeletal 
muscle atrophy after 48 hr food deprivation was determined in tibialis anterior (TA), 
extensor digitorum longus (EDL), soleus (SOL), and gastrocnemius (GAS). (C-D) TRB3 
mRNA (C) and protein expression (D) were determined in TA muscles. (E-G) 
Phosphorylation and total expression of Akt (E), FOXO1 (F), and FOXO3a (G) were 
determined by Western blot analysis. (H) mRNA expression of muscle-specific E3 
ubiquitin ligases was determined by RT-PCR. Data are the means ± S.E.M. (n=4 per 
group). * P < 0.05, ** P < 0.01, *** P < 0.001 vs. Fed.
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Figure 4.2 ER stress is responsible for food deprivation-induced TRB3 expression. 
(A) mRNA expression of multiple ER stress markers was determined in TA muscles by 
RT-PCR after 48 hr starvation. (B) mRNA expression of several ER stress markers was 
analyzed in C2C12 cells after 6 hr PBS and/or 4-PBA treatment. ATF6, activating 
transcription factor 6; ATF4, activating transcription factor 4; CHOP, C/EBP 
homologous protein; XBP1, X-box binding protein 1; GRP78/Bip, glucose-regulated 
protein 78/Binding immunoglobulin protein; eIF2α, eukaryotic translation initiation 
factor 2α. Data are the means ± S.E.M. (n=4 per group for in vivo, n=9 per group for in 
vitro). * P < 0.05, ** P < 0.01, *** P < 0.001 vs. Fed or Control + DMSO.
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Figure 4.3 Muscle-specific TRB3 overexpression increases food deprivation-induced 
skeletal muscle atrophy. Ten- to thirteen-week-old female muscle-specific TRB3 
transgenic (TG) and their wild-type littermate control (WT) mice were used to determine 
the role of TRB3 in skeletal muscle mass regulation under food deprivation-induced 
atrophy conditions. (A) TRB3 overexpression was confirmed by RT-PCR with increased 
TRB3 mRNA expression in TA muscles. TG and WT mice were divided into Fed and FD 
groups and underwent starvation for 48 hr. (B) Percentage change in body weight 
between Fed and FD groups in both WT and TG mice was determined. (C) Percentage of 
food deprivation-induced atrophy was determined in TA, EDL, SOL and GAS muscles. 
Data are the means ± S.E.M. (n=6 per group). *** P < 0.001 vs. Fed, # P < 0.05, ## P < 
0.01 vs. WT. 
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Figure 4.4 TRB3 overexpression in skeletal muscle facilitates the protein 
degradation pathways, including ubiquitin-proteasomal and autophagy-lysosomal 
systems after 48 hr food deprivation. TA muscles from Fed and FD groups in both 
genotypes were used for analysis. (A-C) The phosphorylation of Akt (A), FOXO1 (B), 
and FOXO3a (C) were determined by Western blot analysis. (D) mRNA expression of 
atrogenes was measured by RT-PCR in both genotypes. (E-F) Protein expression of 
atrogin-1 (E) and MuRF-1 (F) was determined by Western blot analysis. (G-H) The 
markers of autophagy-lysosomal protein degradation, including p62 (G) and LC3B (H), 
were analyzed after 48 hr food deprivation. Data are the means ± S.E.M. (n=6 per group). 
P < 0.05, ** P < 0.01, *** P < 0.001 vs. Fed. # P < 0.05, ## P < 0.01 vs. WT.  
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Figure 4.5 Muscle-specific TRB3 overexpression does not augment the effect of food 
deprivation on protein synthesis rate and signaling pathway. TA muscles from fed 
and food deprived muscle-specific TRB3 transgenic (TG) and wild-type littermate 
control (WT) mice were processed for analysis. (A) Western blot with anti-puromycin 
antibody was used to analyze puromycin incorporation into nascent peptides in WT and 
TG mice. Ponceau S staining was used to demonstrate an equal loading of protein. 
Methodology details can be found in Materials and Methods. (B) The amount of 
puromycin incorporation was normalized by ponceau S staining. (C-F) The 
phosphorylation and total expression of mTOR (C), 4EBP1 (D), PRAS40 (E), TSC2 (F) 
were measured by Western blot analysis. Data are the means ± S.E.M. (n=6 – 9 per 
group). * P < 0.05, ** P < 0.01, *** P < 0.001 vs. Fed. # P < 0.05, ## P < 0.01 vs. WT.
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Figure 4.6 TRB3 knockout mice were protected from food deprivation-induced 
atrophy. Ten- to thirteen-week-old female whole-body TRB3 knockout (KO) and wild-
type littermate (WT) mice were used to demonstrate whether TRB3 is a key molecule to 
induce food deprivation-induced atrophy. (A) TRB3 mRNA expression in TA muscle 
was determined to confirm the knockout of TRB3. KO and WT mice were divided into 
Fed and FD groups. (B) Percentage change in body weight between Fed and FD groups 
in both WT and KO mice was determined. (C) Percentage of food deprivation-induced 
atrophy was determined in TA, EDL, SOL and GAS muscles. Data are the means ± 
S.E.M. (n=4 – 6 per group). *** P < 0.001 vs. Fed, # P < 0.05, ### P < 0.001 vs. WT. 
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Figure 4.7 TRB3 knockout maintains protein synthesis rate after 48 hr food 
deprivation. Frozen TA muscles were processed for analysis. (A) Protein synthesis rate 
was measured by Western blot and ponceau S staining represented that an equal amount 
of proteins was loaded for each sample. (B) All puromycin blots were normalized by 
ponceau S staining. (C-F) Protein synthesis pathway factors, including mTOR, 4EBP1, 
PRAS40, and TSC2, was analyzed by Western blot. Data are the means ± S.E.M. (n=6 
per group). * P < 0.05, *** P < 0.001 vs. Fed, # P < 0.05 vs. WT.
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Supplementary Figure S4.1 Forty-eight hours of food deprivation did not change 
Akt phosphorylation at Ser 473. Ten- to thirteen-week-old female C57BL/6 wild-type 
(WT), muscle-specific TRB3 transgenic (TG), TRB3 knockout (KO) mice were 
underwent either free access to food (Fed) or food deprivation (FD) for 48 hr. Tibialis 
anterior (TA) muscles were analyzed to examine food deprivation-induced changes in 
Akt phosphorylation at Ser 473. (A) Two days of food deprivation did not alter the level 
of phosphorylated Akt at Ser 473. (B-C) Phosphorylation of Akt at Ser 473 was not 
affected by 48 hr food deprivation in both TG (B) and KO (C) mice. Data are the means 
± S.E.M. (n=4 – 6 per group).  
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Supplementary Figure S4.2 The effect of 48 hr food deprivation on extensor 
digitorum longus (EDL) muscle from KO mice. Ten- to thirteen-week-old female 
TRB3 knockout (KO) and wild-type littermate (WT) mice were underwent either free 
access to food (Fed) or food deprivation (FD) for 48 hr. EDL muscle were used to 
demonstrate whether knockout of TRB3 prevents food deprivation-induced atrophy. (A-
D) The phosphorylation of Akt (A-B), FOXO1(C), and FOXO3a (D) were determined by 
Western blot analysis. (E-F) Protein expression of atrogin-1 (E) and MuRF-1(F) was 
determined by Western blot analysis. Data are the means ± S.E.M. (n=4 – 6 per group). * 
P < 0.05, ** P < 0.01, *** P < 0.001 vs. Fed. # P < 0.05 vs. WT. 
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Supplementary Figure S4.3 The effect of 48 hr food deprivation on EDL from KO 
mice was not different from TA muscles. Ten- to thirteen-week-old female TRB3 
knockout (KO) and wild-type littermate (WT) mice were underwent either free access to 
food (Fed) or food deprivation (FD) for 48 hr. (A-B) Protein synthesis rate was measured 
by Western blot and ponceau S straining represented that an equal amount of proteins 
was loaded for each sample. (B) All puromycin blots were normalized by Ponceau S 
staining. (C-F) Proteins involved in the protein synthesis pathway, including mTOR (C), 
4EBP1 (D), PRAS40 (E), and TSC2 (F), were analyzed by Western blot. Data are the 
means ± S.E.M. (n=4 – 6 per group). * P < 0.05, ** P < 0.01, *** P < 0.001 vs. Fed. # P 
< 0.05 vs. WT.
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CHAPTER 5 
EFFECTS OF TRB3 ON EXERCISE-INDUCED SKELETAL MUSCLE 
ADAPTATION1
                                                             
1 Choi RH, McConahay A, Johnson M, Koh HJ. To be submitted to Journal of Applied Physiology  
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5.1 ABSTRACT 
Tribbles 3 (TRB3) is a pseudokinase and its expression has been shown to disrupt 
glucose metabolism through the inhibition of Akt under obese and diabetic conditions. 
Previously, we found that TRB3 overexpression in mouse skeletal muscle decreased 
skeletal muscle mass and function, including running capacity. Here, we examined 
whether TRB3 affects exercise training-induced skeletal muscle adaptation. We trained 
muscle-specific TRB3 transgenic (TG) and wild-type (WT) littermates using a voluntary 
wheel running protocol for 6 weeks and observed that TG mice ran significantly shorter 
weekly distances than WT littermates. To eliminate the possibility that different skeletal 
muscle adaptations would be produced due to different training intensities, involuntary 
treadmill exercise (TM) was used as a training regimen. At the 5th week of training, we 
measured glucose tolerance and found that trained TG mice showed glucose intolerance 
compared to WT littermates. Furthermore, TRB3 overexpression significantly suppressed 
the expressions of genes needed for glucose uptake and mitochondrial biogenesis, 
independent of training status. To further determine the role of TRB3 in exercise-induced 
adaptation, TRB3 knockout mice were trained by voluntary and involuntary exercise 
protocols. KO mice presented improved glucose tolerance compared to WT littermates 
independent of training status. However, we did not observe significant change in 
markers of glucose uptake and mitochondrial biogenesis. Taken together, our results 
indicate that TRB3 expression in skeletal muscle may blunt the benefits of exercise-
induced skeletal muscle adaptation.  
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5.2 INTRODUCTION 
Tribbles homolog 3 (TRB3), a mammalian homolog of Drosophila tribbles, is a 
pseudokinse, which lacks catalytic function, thus it serves as a molecular scaffold 
(Boudeau et al., 2006). It is responsible for various cellular events including glucose 
regulation, endoplasmic reticulum stress response, differentiation of skeletal muscle cells 
and adipocytes, and cell cycle regulation (Du et al., 2003; Kato & Du, 2007; Ohoka et al., 
2005; Ord et al., 2007; Takahashi, Ohoka, Hayashi, & Sato, 2008).  
For decades, many studies have investigated and confirmed the finding that TRB3 
has a negative effect on Akt phosphorylation, which is a major process for glucose and 
lipid metabolism in metabolic regulatory tissues, such as liver and skeletal muscle (Du et 
al., 2003; Zhang et al., 2013). For instance, hepatic TRB3 expression decreases 
phosphorylation of Akt and impairs glucose tolerance, while TRB3 knockdown improves 
hepatic glucose regulation (Du et al., 2003). In skeletal muscle, muscle-specific TRB3 
overexpression worsens high-fat diet-induced obesity and decreases phosphorylation of 
Akt and glycogen synthase kinase 3 (GSK3), while muscle-specific TRB3 knockout 
improved glucose homeostasis with high-fat diet (HFD) feeding (Zhang et al., 2013). Our 
lab has also recently demonstrated that muscle-specific TRB3 overexpression in healthy 
conditions and under food deprivation-induced atrophic states can regulate skeletal 
muscle mass by altering protein turnover through the regulation of Akt and its 
downstream molecules, for instance, mechanistic target of rapamycin (mTOR) and 
forkhead box O transcription factors (FOXO) (R. H. Choi et al., 2017; R. H. Choi et al., 
2019). Given the findings that TRB3 could be an important regulator of skeletal muscle 
mass and integrity, we hypothesized that TRB3 may significantly alter the exercise-
induced adaptation to skeletal muscle.  
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Skeletal muscle, which composes 40-50% of body mass, is a major organ that 
regulates whole body energy metabolism because it is responsible for ~80% of 
postprandial glucose uptake (DeFronzo & Tripathy, 2009). Continuous contractile 
activity, such as that elicited by exercise, has been associated with improved glucose and 
oxidative metabolism in skeletal muscle (Arena et al., 2017; Baar et al., 2002; Dela et al., 
2006). Exercise-induced improvements in glucose metabolism are associated with 
increased expressions and functions of glucose transporters and metabolic enzymes in 
skeletal muscle. Previous studies have found that glucose transporter 4 (GLUT4) mRNA 
expression is increased after exercise (Kraniou et al., 2006; Kuo et al., 1999), but protein 
expression after exercise can vary (Frosig et al., 2010; Leick et al., 2010). In addition to 
increased GLUT4, it has been reported that a single bout of exercise can increase 
hexokinase II (HXKII) expression and enzymatic activity in skeletal muscle, which 
improves glucose metabolism (O'Doherty et al., 1996; O'Doherty et al., 1994). Exercise-
induced oxidative capacity and metabolic efficiency are elicited by increased 
mitochondrial biogenesis (Pilegaard et al., 2003). Peroxisome proliferator-activated 
receptor gamma co-activator 1α (PGC1α) is highlighted as a key regulator of 
mitochondrial biogenesis in skeletal muscle in response to endurance exercise (Baar et 
al., 2002; J.O. Holloszy, 1967). PGC1α is a transcription factor that can coordinate the 
expression of genes related to mitochondrial biogenesis, such as mitochondrial 
transcription factor A (TFAM), cytochrome oxidase (COX) 1 and 4, and cytochrome c 
(Cyt c) (Yan, Okutsu, Akhtar, & Lira, 2011). Previously, muscle-specific PGC1α 
knockout mice showed impaired muscle function, locomotion, and oxidative capacity, 
but muscle-specific PGC1α knockout did not prevent exercise-induced COX and Cyt c 
expression (Geng et al., 2010; Handschin et al., 2007).  
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Increased TRB3 expression has been found in the liver and skeletal muscle from 
obese and diabetic rodent models, including ob/ob and HFD-induced obese mice, and this 
increased TRB3 was decreased in response to acute and chronic endurance exercise 
(Lima et al., 2009; Marinho et al., 2012; Matos et al., 2010). In addition, reduced TRB3 
expression is associated with increased phosphorylation of Akt and improved glucose 
metabolism (Lima et al., 2009; Marinho et al., 2012; Matos et al., 2010). One recent 
study has shown that muscle-specific TRB3 transgenic mice display increased exercise 
capacity with greater amount of oxidative fibers (An et al., 2014). Although there is some 
evidence that TRB3 is regulated by exercise, the effect of TRB3 on exercise training-
induced skeletal muscle adaptation has not been elucidated.  
In the current study, we investigate whether TRB3 expression in mouse skeletal 
muscle will disrupt exercise-induced skeletal muscle adaptation, including glucose uptake 
and mitochondrial biogenesis. Our findings show that muscle-specific TRB3 transgenic 
(TG) mice run significantly shorter distances than wild-type (WT) littermates when they 
are trained by voluntary wheel running. TG mice display significantly suppressed gene 
expressions of GLUT4 and HXKII compared to WT littermates. Furthermore, TRB3 
overexpression represses the expression of genes responsible for mitochondrial contents, 
such as PGC1α, COX4, and Cyt c in both sedentary and trained groups. TRB3 knockout 
(KO) mice have better glucose tolerance than WT littermates independent of training 
status, but there is no significant improvement in exercise-induced skeletal muscle 
adaptation at the molecular level. Taken together, these results indicate that TRB3 
expression in skeletal muscle may blunt the benefits of exercise in glucose uptake and 
mitochondrial biogenesis.  
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5.3 MATERIALS AND METHODS 
Animal care  
Ten- to fourteen-week-old muscle-specific TRB3 transgenic (TG) and whole-
body TRB3 knockout (KO) mice, and their wild-type littermates were used for the 
current study. All animals were fed standard chow diet (Harlan Teklad Diet, Madision, 
WI, USA) and accessed water ad libitum. Mice were maintained in the animal facility at 
the University of South Carolina and were housed in an environmentally controlled room 
on a 12 hr light-dark cycle. All protocols were approved by the Institutional Animal Care 
and Use Committee of the University of South Carolina.  
Voluntary wheel cage exercise  
Mice were randomly assigned to housing in individual cages with or without 
running wheels (9.5 inch in diameter) for 6 weeks. Mice freely accessed to wheel (Mini 
Mitter company, Sunriver, OR, USA). Daily activities, including running time and wheel 
revolutions, were monitored by computer monitoring software Vital View (Starr Life 
Science Corp., Oakmont, PA, USA). Average daily running distance and 6-week total 
running distance were calculated from the monitored data using Microsoft excel. Before 
sacrifice, the wheels were removed from the cage for 48 h to minimize acute exercise 
effect.  
Involuntary treadmill running protocol 
Separated ten- to fourteen-week old TG and WT mice were randomly assigned to 
treadmill exercise groups. All mice in exercise groups had an acclimation period for 3 
days on the treadmill (Columbus instruments treadmill simplex II, Columbus, OH, USA) 
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for 10 min at 8 meters/minute speed. For the 1st week of the training, mice ran for 1 h/day 
at 12 meters/minutes at 5 degrees incline for 5 days/week. From the 2nd week to last 
week, running speed was increased up to 16 meters/minutes and remained the same for 6 
weeks.  
Glucose tolerance test  
At week 5, mice were transported from wheel cages to normal cages and 
underwent overnight 16 h fasting to determine glucose tolerance. After 16 h fasting, 
fasting blood glucose was determined. Glucose (2 g/kg body weight) was 
intraperitoneally injected. Blood glucose was measured by a glucometer (Bayer, 
Leverkusen, Germany) at 15, 30, 45, 60, 90, and 120 minutes after the injection.  
Muscle glycogen content 
Frozen gastrocnemius muscles were pulverized and used to detect glycogen 
content after exercise training. The content was determined by hydrochloric acid 
hydrolysis for 2 h at 95 ℃ followed by sodium hydroxide neutralization. Then, the 
concentration was measured spectrophotometrically using a hexokinase-based assay kit 
(Sigma, St. Louis, MO).  
Citrate synthase activity 
Citrate synthase activity was determined spectrophotometically in gastrocnemius 
muscle as previously described (Srere, 1969). Gastrocnemius muscles were pulverized 
and used 5 – 7 mg of muscle to measure the enzyme activity. Homogenates were 
incubated with substrate and cofactors at room temperature and the working wavelength 
is 412 nm to detect the reaction product thionitrobenzoic acid.  
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Body weight, food intake, blood glucose and body composition 
Body weight, food intake, and blood glucose were monitored weekly at the same 
time. Body composition was assessed at week 5. Mice were briefly anesthetized by 
isoflurane inhalation and assessed for percentage fat and lean mass by dual-energy X-ray 
absorptiometry (DEXA; Lunar PIXmus, Madison, WI).  
Western blot analysis  
Frozen gastrocnemius muscles was used to prepare protein lysates for Western 
blot analysis as previously described (R. H. Choi et al., 2019). Protein lysates (30 µg) 
were separated on 7 – 15% of SDS-polyacrylamide gels and transferred to PVDF 
membranes. Primary and secondary antibodies purchased from commercial sources, 
including GLUT4 (07-1404; Millipore, Billerica, MA, USA), hexokinase II (sc-3521; 
Santa Cruz Biothechnology Inc., Dallas, TX, USA), PGC1α (ab5441; Abcam, 
Cambridge, MA, USA), COX4 (4844), Cyt c (4280) from Cell Signaling Technology 
(Danvers, MA, USA), TRB3 (ST1032; Calbiochem, San Diego, CA, USA), anti-rabbit 
(NA934; GE healthcare, Pittsburgh, PA, USA) and anti-goat (31400; Thermo Fisher 
Scientific, Waltham, MA, USA) IgG-horesradish peroxidase conjugated secondary 
antibodies. The specific bands were visualized using ECL reagents (NEL105001EA; 
PerkinElmer, Waltham, MA, USA), and the intensity of bands was quantified using 
Image Studio Lite (LI-COR Biosciences, Lincoln, NE, USA).  
RNA extraction and RT-PCR  
Total RNA was extracted from TA muscles using Trizol reagent (Life 
Technologies, Carlsbad, CA, USA) according to the manufacturer’s instruction. cDNA 
was synthesized from 4 mg of total RNA by High Capacity cDNA kit (Life 
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Technologies, Carlsbad, CA, USA). cDNA and primers for real-time polymerase chain 
reaction (RT-PCR) was carried by SYBR green PCR master mix (Life Technologies, 
Carlsbad, CA, USA). Primer sequences used to analyze exercise-induced glucose 
metabolism and oxidative capacity can be found in Table 5.1. All genes were normalized 
to the level of 18S, a house keeping gene. 
Statistical analysis  
Data were expressed as mean ± SEM. Statistical analysis was performed using 
GraphPad Prism 7 software (La Jolla, CA, USA). Student’s two-tailed unpaired t tests 
were used for comparisons between two groups. One- or two-way ANOVA was 
conducted to determine significance between more than two group followed by Tukey’s 
or Bonferroni’s Post hoc analysis. P < 0.05 was considered statistically significant.  
 
5.4 RESULTS 
Muscle-specific TRB3 transgenic mice run shorter distances 
We report in a previous study that increased TRB3 in skeletal muscle under stress 
conditions, including ER stress and HFD, impairs insulin-stimulated Akt phosphorylation 
and whole-body metabolism, and TRB3 knockout abolishes the development of HFD-
induced insulin resistance (Koh et al., 2013). Furthermore, our recent study demonstrates 
that TRB3 overexpression in mouse skeletal muscle disrupts protein turnover, which in 
turn worsens food deprivation-induced atrophy (R. H. Choi et al., 2019). Based on these 
findings, we hypothesized that TRB3 expression would play a significant role in 
exercise-induced skeletal muscle adaptation. In order to test our hypothesis, we 
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individually housed wild-type (WT) littermates and muscle-specific TRB3 transgenic 
(TG) mice in cages with or without wheels for 6 weeks. We weekly monitored body 
weight, food intake, and random blood glucose. No significant difference was observed 
in any parameter between the groups (Table 2). The percentage of fat and lean mass was 
determined by DEXA, and no changes were observed between sedentary and voluntary 
wheel (VW) groups (Table 2). After 6 weeks of training, gastrocnemius muscles were 
removed and used for analysis. TRB3 mRNA expression was not significantly altered by 
VW in either WT or TG mice (Fig. 1A). Intriguingly, we observed that TG mice ran 
significantly shorter distances per week than WT littermates (Fig. 1B). These results 
suggest that muscle-specific TRB3 overexpression may reduce exercise capacity.  
TRB3 overexpression in mouse skeletal muscle causes deterioration of glucose 
metabolism in response to 6-week treadmill training 
Since we observed that TG mice ran significantly shorter distances compared to 
WT littermates, we speculated that since the mice received different training intensities, 
this could result in different adaptation effects between genotypes. Thus, we utilized an 
involuntary exercise protocol, forced treadmill running (TM), to give all mice the same 
amount of exercise. WT littermates and TG mice were encouraged to run on the treadmill 
for 6 weeks (details of this procedure can be found in Materials and Methods section). 
During the 6-week TM training, body weight did not differ between the groups (Table 3). 
However, we observed that TM groups showed significantly reduced body fat and 
increased lean mass compared to sedentary groups (Table 3). To investigate whether 
TRB3 was responsive to forced involuntary exercise, we measured TRB3 mRNA 
expression. TM running did not alter TRB3 mRNA expression in WT mice, but TG mice 
showed a greater increase in the mRNA expression in response to the training (Fig. 2A). 
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Next, to determine whether TRB3 overexpression regulates glucose metabolism in 
response to involuntary exercise, we tested glucose tolerance 5 weeks after the training. 
In trained WT mice, glucose tolerance was slightly improved, but not by a statistically 
significance amount (Fig. 2B and C). TG mice in both sedentary and trained groups 
tended to maintain higher blood glucose during 120-min test periods and showed a higher 
area under the curve, indicating impaired glucose tolerance (Fig. 2B and C). We further 
analyzed molecular markers associated with exercise-induced skeletal muscle glucose 
uptake. Trained WT mice showed no alteration of GLUT4 protein or mRNA expression, 
while hexokinase II (HXKII) was highly elevated (Fig. 2D – F). Interestingly, TG mice 
showed slightly increased GLUT4 and HXKII protein expression in response to TM 
training; however, we found that the mRNA expression of both markers was notably 
suppressed in both sedentary and trained TG mice (Fig. 2D – F). The exercise-induced 
adaption in glucose uptake and enzymatic activity has been associated with increased 
post-exercise glycogen storage (Ivy & Kuo, 1998). Therefore, we measured muscle 
glycogen contents. No significant differences were detected among groups; however, TG 
mice tended to show lower amounts of glycogen after training compared to WT 
littermates (Fig. 2G). These results indicate that TRB3 overexpression in mouse skeletal 
muscle impairs the benefits of exercise on glucose metabolism by suppressing gene 
expression.  
Muscle-specific TRB3 overexpression represses exercise-induced mitochondrial 
biogenesis 
Endurance exercise training is known to increase oxidative metabolism in skeletal 
muscle by increasing the number and size of mitochondria (Baar et al., 2002; J.O. 
Holloszy, 1967). This process is mediated by a transcription coactivator peroxisome 
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proliferator-activated receptor-gamma coactivator 1α (PGC1α). It has been reported that 
both a single bout of exercise and prolonged training can activate PGC1α, resulting in the 
regulation of other transcription factors related to mitochondrial protein and function 
(Baar et al., 2002; J.O. Holloszy, 1967). Previous research has demonstrated that TRB3 is 
a mediator of PGC1α-induced insulin resistance in mouse liver (Koo et al., 2004). 
Furthermore, muscle-specific PGC1α transgenic mice have shown a paradoxical effect 
with regard to glucose metabolism, and have displayed a two-fold increase in TRB3 
expression in their skeletal muscle (C. S. Choi et al., 2008). The previous findings 
suggest a close relationship between TRB3 and PGC1α in skeletal muscle; however, no 
research has investigated whether TRB3 expression affects exercise training-induced 
mitochondrial biogenesis. Therefore, we next tested markers associated with 
mitochondrial biogenesis and oxidative metabolism. Six-week treadmill training 
increased the protein expression of mitochondrial biogenesis markers, such as PGC1α, 
COX4, and Cyt c, in WT mice without altering mRNA expression. (Fig. 3A – D). 
Furthermore, muscle-specific TRB3 overexpression slightly increased PGC1α and Cyt c 
protein expression, but significantly reduced COX4 protein expression in trained TG 
mice compared to trained WT mice (Fig 3. A – C). Intriguingly, TG mice showed 
dramatically suppressed gene expressions of mitochondrial content markers, such as 
PGC1α, COX4, and citrate synthase (CS), compared to WT littermates in both sedentary 
and training conditions (Fig. 3D). Therefore, we tested CS activity to examine whether 
repressed CS gene expression would affect physiological enzymatic activity. We found 
that TM training slightly increased CS activity, but it did not reach statistical significance 
independent of genotypes (Fig. 3E). These results indicate that muscle-specific TRB3 
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overexpression may debilitate exercise-induced mitochondrial adaptation by suppressing 
the expression of genes necessary for mitochondrial biogenesis. 
TRB3 knockout improves glucose tolerance but does not augment the benefits of 
exercise in glucose metabolism 
In the present study, we found that TRB3 overexpression in mouse skeletal 
muscle blunted exercise training-induced skeletal muscle adaptation by repressing gene 
expression. Therefore, we considered that a deletion of TRB3 in skeletal muscle might 
enhance exercise-induced skeletal muscle adaptation. To examine the hypothesis, we next 
recruited TRB3 knockout (KO) mice and WT littermates for exercise training with 
voluntary wheel running (details found in the Materials and Methods section). During 6-
week VW training, there were no significant changes in body weight, food intake, blood 
glucose, or body composition among the groups (Table 4). KO mice ran slightly more 
often than WT littermates, but the increase did not reach to a statistical difference (Table 
4). To examine the effect of TRB3 knockout on exercise-induced improvement in 
glucose metabolism, we measured glucose tolerance after overnight fasting at the 5th 
week of the training. Exercise training likely improved glucose tolerance in WT and KO 
mice during the120-min test period (Fig. 4A). Interestingly, trained KO mice showed 
significantly lower blood glucose than trained WT mice at the 60-min time (Fig. 4A). 
These results were clearly reflected in the area under the curve: TRB3 knockout tended to 
improve glucose tolerance in sedentary animals and after training (Fig. 4B). To 
investigate the possible mechanism for improved glucose tolerance in KO mice, we 
measured GLUT4 and HXKII expressions. In WT littermates, there was no change in 
GLUT4 protein and mRNA expression, but HXKII was greatly increased in response to 
VW exercise (Fig 4C – E). VW running did not alter GLUT4 expression in KO mice but 
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did slightly increase HXKII protein expression (Fig 4C and D). Furthermore, KO mice 
displayed significantly reduced mRNA expression of GLUT4 and HXKII in response to 
VW training (Fig. 4E). Muscle glycogen content was slightly increased in WT mice after 
training. KO mice tended to show more glycogen content in sedentary status, but exercise 
training produced no other effects (Fig. 4F). These results suggest that TRB3 knockout 
improves glucose tolerance in sedentary and trained conditions, but that the improved 
glucose tolerance is not due to changes in GLUT4 or HXKII expressions.  
TRB3 knockout does not facilitate mitochondrial adaptation in response to VW 
exercise training 
We observed that TRB3 overexpression in mouse skeletal muscle significantly 
abrogated the expression of genes responsible for mitochondrial biogenesis (Fig. 3D). To 
determine whether TRB3 knockout accelerates the regulation of exercise-induced 
mitochondrial adaptation, we examined mitochondrial markers at the protein and mRNA 
levels. Six-week VW training increased mitochondrial markers, including PGC1α, 
COX4, and Cyt c, in both trained WT and KO mice compared to sedentary groups (Fig. 
5A – C). Consistent with protein expression, trained WT mice showed greatly increased 
mRNA expression of mitochondrial biogenesis markers, such as PGC1α, COX1 and 4, 
and CS (Fig. 5D). Surprisingly, TRB3 knockout mice did not show any significant 
changes in the expression of genes needed for mitochondrial biogenesis in response to 
VW (Fig. 5D). To further examine whether TRB3 knockout affects mitochondrial 
enzymatic activity, we measured CS activity and found a notable increase in the activity 
after VW running in both genotypes (Fig. 5E). These results indicate that TRB3 knockout 
does not further promote mitochondrial biogenesis markers after VW exercise training.  
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TRB3 knockout does not benefit exercise training-induced metabolic adaptations in 
response to involuntary running 
 In the present study, we have found that TRB3 knockout did not further assist 
exercise-induced skeletal muscle adaptation even though KO mice were likely to show a 
better glucose tolerance than WT mice (Fig. 4A and B). To eliminate the possibility of 
the mice receiving different intensities of exercise due to the voluntary exercise protocol, 
we repeated the experiment using an involuntary exercise protocol, forced treadmill 
running (see Materials and Methods section for details). There were no differences in 
body weight, food intake, or blood glucose among the groups during the 6-week training 
period (Table 5). However, we did observe a significant reduction in fat mass in KO mice 
after TM training compared to WT mice (Table 5). Next, the mice underwent a glucose 
tolerance test at the 5th week of the training. There was no noticeable difference in 
glucose tolerance among the groups (Fig. 6A). In KO mice, both sedentary and trained 
mice showed a lower area under the curve compared to WT mice, suggesting improved 
glucose tolerance (Fig. 6B). We also analyzed GLUT4 and HXKII to determine possible 
mechanisms for improved glucose tolerance. GLUT4 and HXKII were increased in both 
WT and KO mice in response to the involuntary running protocol (Fig. 6D – E). 
Furthermore, TM running slightly depleted muscle glycogen in both genotypes, but we 
did not find any statistical difference (Fig. 6F). Mitochondrial contents at the protein and 
mRNA levels showed a tendency to respond to TM running, but there were no 
remarkable differences between genotypes (Fig. 7A – D). In CS activity, TRB3 knockout 
increased CS activity in response to TM exercise while WT littermates did not show any 
response to the training (Fig. 7E). Taken together, these data suggest that TRB3 knockout 
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improves glucose tolerance regardless of training status or types of training, but TRB3 
knockout does not benefit exercise-induced skeletal muscle adaptation.  
 
5.5 DISCUSSION 
TRB3 is known to inhibit Akt phosphorylation, and increased TRB3 expression is 
associated with metabolic dysfunction in multiple tissues, including the liver and skeletal 
muscle (Koo et al., 2004; Zhang et al., 2016). In addition, a reduction of TRB3 
expression in obese and diabetic mouse models has been observed in response to acute 
and chronic exercise, resulting in amelioration of metabolic stress (Lima et al., 2009; 
Marinho et al., 2012; Matos et al., 2010). Although research has demonstrated that TRB3 
is strongly associated with metabolic dysregulation in the liver under obese and diabetic 
conditions, the role of TRB3 in skeletal muscle has not been clearly understood. Our 
previous studies demonstrated that TRB3 plays an important role in the regulation of 
protein turnover in skeletal muscle at the basal level and under food deprivation-induced 
atrophy (R. H. Choi et al., 2017; R. H. Choi et al., 2019). To further determine the role of 
TRB3 in skeletal muscle, we examined the effects of TRB3 on exercise training-induced 
skeletal muscle adaptation with regard to glucose uptake and mitochondrial biogenesis. 
Our findings indicate that muscle-specific TRB3 overexpression cause deterioration in 
glucose tolerance and also suppresses the expression of genes responsible for glucose 
uptake and mitochondrial biogenesis regardless of exercise training. By contrast with the 
detrimental effects of TRB3 overexpression, TRB3 knockout improves glucose tolerance 
in both sedentary and trained groups; however, there were no further improvements in 
glucose uptake or mitochondrial biogenesis between genotypes in response to exercise 
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training. These findings suggest a possible role for TRB3 in exercise-induced skeletal 
muscle adaptation: the regulation of whole-body metabolism and oxidative capacity.  
In the current study, we observed that voluntary wheel running did not alter TRB3 
expression in either WT or TG mice, and involuntary treadmill training greatly increased 
TRB3 expression in TG mice only (Fig. 1A and 2A). Previously, An et al. reported that 
4-week voluntary exercise increases TRB3 mRNA and protein expression in C57BL/6 
WT mice (An et al., 2014). However, we did not observe an increase of TRB3 expression 
in WT littermates in response to either exercise training protocols. This inconsistency 
may be due to different types of training procedures, intensity, and duration. Our mice 
ran about 20 km/week for 6 weeks compared to about 46 km/week for 4 weeks based on 
An et al.’s report. This difference in running distance raises the possibility of different 
responses. Future study may be required using similar intensity, duration, and training 
protocols to produce comparable results. Furthermore, we found increased TRB3 
expression in TG mice only after involuntary exercise (Fig. 2A). This discrepancy could 
be due to sex difference in the mice that we used for each study and/or to different 
training procedures. There are several reports of female and male mice showing different 
consequences after exercise training (De Bono, Adlam, Paterson, & Channon, 2006; 
Konhilas et al., 2004). As the relationship between TRB3 expression and sex different is 
unknown, further study would be necessary to reveal any relationship involving sex 
difference.  
Exercise training promotes glucose uptake in skeletal muscle with increasing 
GLUT4 expression and HXKII enzymatic activity (Cusi et al., 2001; Derave et al., 1999; 
Rodnick, Henriksen, James, & Holloszy, 1992). Several previous studies have reported 
that GLUT4 protein and mRNA expression can vary due to different experiment settings 
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and exercise intensities (Frosig et al., 2010; Kuo et al., 1999; Leick et al., 2010). In the 
current study, we found that GLUT4 protein expression was not altered by exercise 
training in either genotype (Fig. 2D), but TRB3 overexpression significantly decreased 
gene expression of GLUT4 in sedentary and trained groups (Fig. 2F). TRB3 
overexpression repressed HXKII mRNA expression as well. HXKII is a rate-limiting 
enzyme in glycolysis known to be responsible for exercise-induced glucose uptake 
(O'Doherty et al., 1996; O'Doherty et al., 1994). Furthermore, impaired glucose uptake 
and exercise capacity have been observed in HXKII knockout mice in response to 
exercise training (Fueger et al., 2003; Fueger et al., 2005). Given the importance of 
GLUT4 and HXKII in glucose uptake, suppressed GLUT4 and HXKII gene expressions 
in mouse skeletal muscle may induce impaired glucose tolerance in TG mice (Fig. 2B 
and C). Moreover, the decreased gene expressions in TG mice possibly impairs exercise 
capacity, as we observed shorter distances in voluntary running training caused by a 
disruption of energy substrate utilization (Fig. 1B). The mechanism(s) by which TRB3 
regulates the expressions of genes responsible for metabolism remains to be answered.  
Endurance exercise training also stimulates mitochondrial biogenesis. PGC1α is 
considered to be a main regulator of exercise-induced mitochondrial biogenesis (Baar et 
al., 2002). Muscle-specific overexpression of PGC1α increases slow-type fibers and 
improves exercise capacity (Lin et al., 2002; Wende et al., 2007), while muscle-specific 
PGC1α knockout mice show decreased daily locomotion and attenuated exercise-induced 
mitochondrial biogenesis (Handschin et al., 2007). We observed that TG mice displayed 
significantly lower PGC1α mRNA expression with no further increment after exercise 
training, and that they also show remarkably reduced the expressions of genes necessary 
for mitochondrial biogenesis independent of training status (Fig. 3D). In addition, it has 
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been demonstrated that PGC1α overexpression in the liver and skeletal muscle impair 
glucose homeostasis by levating hepatic TRB3 expression (C. S. Choi et al., 2008; Koo et 
al., 2004). Although the role of TRB3 in regulating PGC1α expression has not been 
elucidated, we believe our results offer at least the possibility that TRB3 overexpression 
impairs PGC1α expression and disrupts the regulation of exercise-induced mitochondrial 
biogenesis.  
In the present study, TRB3 knockout mice seem to demonstrate improved glucose 
tolerance compared to WT littermates, independent of training status (Fig. 5B and 6B). 
Previously, our lab has shown that TRB3 knockout prevents HFD-induced development 
of insulin resistance (Koh et al., 2013). This would be the first observation of TRB3 
knockout possibly benefiting whole-body glucose tolerance under normal healthy 
conditions, regardless of exercise training. However, we did not detect any further 
changes in protein or mRNA expressions of GLUT4 or HXKII (Fig. 4C – E, 5C – E). 
These results suggest that improved glucose tolerance in KO mice is possibly caused by 
other mechanisms than GLUT4 and HXKII expression, which can regulate glucose 
metabolism, involve in the improved glucose tolerance in KO mice.  
Taken together, our data suggest that muscle-specific TRB3 overexpression might 
impair exercise capacity and glucose tolerance in response to exercise training via the 
regulation of transcriptions of genes responsible for glucose uptake and mitochondrial 
biogenesis. We have also demonstrated that the lack of TRB3 might improve glucose 
tolerance, independent of training status. The current study elucidates the possibility that 
TRB3 expression could affect glucose metabolism and mitochondrial biogenesis in 
response to exercise training. Additional works are necessary to find the molecular 
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mechanism(s) by which TRB3 regulates transcriptional activity of the genes responsible 
for glucose uptake and mitochondrial biogenesis.  
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Table 5.1 Primer sequences for RT-PCR 
GLUT4, glucose transporter 4; PGC1α, Peroxisome proliferator-activated receptor 
gamma co-activator 1 α; TFAM, mitochondrial transcription factor A; COX1, 
cytochrome oxidase 1; COX4, cytochrome oxidase 4; Cyt c, cytochrome c 
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Table 5.2 Characteristics of TG mice in voluntary wheel cage exercise 
 
Ten- to fourteen-week old male female wild-type (WT) littermates and muscle-specific 
TRB3 transgenic (TG) mice were randomly assigned in two groups; sedentary (Sed) and 
voluntary wheel (VW) running for 6 weeks. Data are means ±SEM (n=4/group).
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Figure 5.1 Muscle-specific TRB3 overexpression impairs exercise capacity as 
measured by 6-week voluntary wheel running. Ten- to fourteen-week old female wild-
type (WT) littermates and muscle-specific TRB3 transgenic (TG) mice were separated in 
sedentary (Sed) and voluntary wheel (VW) running group for 6 weeks. (A) TRB3 
expression was determined in gastrocnemius. (B) Wheel activity was monitored by the 
software and weekly average distance was determined. Data are means ±SEM 
(n=4/group). ** P<0.01 vs. WT 
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Table 5.3 Characteristics of TG mice in treadmill exercise  
Ten- to fourteen-week old male wild-type (WT) littermates and muscle-specific TRB3 
transgenic (TG) mice were randomly assigned in two groups; sedentary (Sed) and 
involuntary treadmill (TM) training for 6 weeks. Data are means ±SEM (n=4/group). * 
P<0.05 vs. Sed. 
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Figure 5.2 Muscle-specific TRB3 overexpression deteriorates glucose uptake in 
response to 6-week treadmill training. Ten- to fourteen-week old male wild-type (WT) 
littermates and muscle-specific TRB3 transgenic (TG) mice were randomly assigned in 
sedentary (Sed) and involuntary treadmill (TM) training groups for 6 weeks. (A) After 6 
weeks of training, TRB3 mRNA expression was measured in gastrocnemius muscle. (B-
C) At 5th week, glucose tolerance (B) was tested in sedentary (Sed) and treadmill (TM) 
trained mice and the results were represented as area under the curve (C). (D-E) Protein 
expressions of glucose transporter 4 (GLUT4; D) and hexokinase II (HXKII; E) were 
analyzed by Western blot. (F) GLUT4 and HXKII mRNA expression was determined by 
RT-PCR. (G) Muscle glycogen content were measured in gastrocnemius muscle. Data are 
means ±SEM (n=4/group). * P<0.05, ** P<0.01 vs. Sed; # P <0.05, ## P<0.01, ### 
P<0.001 vs. WT. 
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Figure 5.3 Muscle-specific TRB3 overexpression represses gene expressions of 
mitochondrial biogenesis markers. Ten- to fourteen-week old male wild-type (WT) 
littermates and muscle-specific TRB3 transgenic (TG) mice were randomly assigned in 
sedentary (Sed) and involuntary treadmill (TM) training groups for 6 weeks. (A-C) 
Protein expression of PGC1α (A), COX4 (B), and Cyt c (C) were determined by Western 
blot. (D) The expression of genes for mitochondrial contents were measured by RT-PCR. 
(E) Citrate synthase activity was measured in gastrocnemius to determine oxidative 
function in response to exercise training. Data are means ±SEM (n=4/group). * P<0.05, 
** P<0.01 vs. Sed; # P <0.05, ## P<0.01, ### P<0.001 vs WT. 
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Table 5.3 Characteristics of KO mice in voluntary wheel exercise 
 
Ten- to fourteen-week old female wild-type (WT) littermates and TRB3 knockout (KO) 
mice were randomly assigned in two groups; sedentary (Sed) and voluntary wheel (VW) 
training for 6 weeks. Data are means ±SEM (n=4-5/group). 
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Figure 5.4 TRB3 knockout improves glucose tolerance but does not augment the 
benefits of exercise in glucose uptake. Ten- to fourteen-week old female wild-type 
(WT) littermates and TRB3 knockout (KO) mice were divided into sedentary (Sed) and 
voluntary wheel (VW) training groups for 6 weeks. (A-B) At 5th week of training, 
glucose tolerance (A) was measured to determine glucose metabolism and the results 
were represented as area under the curve (B). (C-D) Protein expressions of glucose 
transporter 4 (GLUT4; C) and hexokinase II (HXKII; D) were analyzed by Western blot. 
(E) GLUT4 and HXKII mRNA expression was determined by RT-PCR. (F) Muscle 
glycogen content were measured in gastrocnemius muscle. Data are means ±SEM (n=4-
5/group). * P<0.05 vs. Sed; # P <0.05, ## P<0.01 vs. WT. 
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Figure 5.5 TRB3 knockout dose not facilitate mitochondrial adaptation in response 
to VW training. Ten- to fourteen-week old female wild-type (WT) littermates and TRB3 
knockout (KO) mice were divided into sedentary (Sed) and voluntary wheel (VW) 
training groups for 6 weeks. After 6 weeks of training, gastrocnemius muscles were 
analyzed. (A-C) Protein expression of PGC1α (A), COX4 (B), and Cyt c (C) were 
determined by Western blot. (D) The expression of genes for mitochondrial contents 
were measured by RT-PCR. (E) Citrate synthase activity was measured to determine 
oxidative function in response to exercise training. Data are means ±SEM (n=4-5/group). 
* P<0.05, ** P<0.01 vs. Sed; # P <0.05, ## P<0.01, ### P<0.001 vs WT. 
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Table 5.4 Characteristics of KO mice in treadmill exercise  
 
Ten- to fourteen-week old male wild-type (WT) littermates and TRB3 knockout (KO) 
mice were randomly assigned in two groups; sedentary (Sed) and involuntary treadmill 
(TM) training for 6 weeks. Data are means ±SEM (n=4/group). # P<0.05 vs. WT 
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Figure 5.6 TRB3 knockout does not further improve molecular markers for glucose 
uptake in response to involuntary exercise. Ten- to fourteen-week old male wild-type 
(WT) littermates and TRB3 knockout (KO) mice were divided into sedentary (Sed) and 
involuntary treadmill (TM) training groups for 6 weeks. (A-B) At 5th week of TM 
training, glucose tolerance (A) was measured to determine glucose metabolism and the 
results were represented as area under the curve (B). (C-D) Protein expressions of 
glucose transporter 4 (GLUT4; C) and hexokinase II (HXKII; D) were analyzed by 
Western blot. (E) GLUT4 and HXKII mRNA expression was determined by RT-PCR. 
(F) Muscle glycogen content were measured in gastrocnemius muscle. Data are means 
±SEM (n=4/group). * P<0.05 vs. Sed. 
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Figure 5.7 TRB3 knockout does not promote mitochondrial biogenesis in response 
to involuntary treadmill exercise. Ten- to fourteen-week old female wild-type (WT) 
littermates and TRB3 knockout (KO) mice were divided into sedentary (Sed) and forced 
treadmill (TM) training groups for 6 weeks. After 6 weeks of training, gastrocnemius 
muscles were analyzed. (A-C) Protein expression of PGC1α (A), COX4 (B), and Cyt c 
(C) were determined by Western blot. (D) The expression of genes for mitochondrial 
contents were measured by RT-PCR. (E) Citrate synthase activity was measured to 
determine oxidative function in response to exercise training. Data are means ±SEM 
(n=4-5/group). * P<0.05, ** P<0.01 vs. Sed; # P <0.05 vs WT. 
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CHAPTER 6 
OVERALL DISCUSSION
 121 
Skeletal muscle displays high plasticity, adapting its function and structure in 
response to various stimuli, such as nutrients, hormones, and muscle contractions. The 
loss of muscle mass and integrity has been associated with an increasing prevalence of 
chronic diseases, including hypertension, type 2 diabetes, obesity, and cancer. Therefore, 
maintenance of skeletal muscle mass and function is considered as a powerful strategy in 
preventing and overcoming pathological conditions. The IGF-1/PI3K/Akt pathway is 
known to be a major signaling cascade that regulates energy metabolism and protein 
turnover in skeletal muscle. Although the role of Akt in energy metabolism and protein 
turnover has been studied for decades, only a few studies have defined a direct regulator 
of Akt activity. TRB3 has been identified as a negative regulator of Akt via a direct 
binding to phosphorylation sites (Du et al., 2003). Its expression is found in multiple 
tissues, including the liver and skeletal muscle. Since TRB3 is strongly expressed in the 
liver and its function is associated with the inhibition of Akt, resulting in metabolic 
dysregulation, previous research has focused on the effects of TRB3 on metabolic 
dysregulation, such as insulin resistance (Du et al., 2003; Koo et al., 2004). As previously 
stated, Akt is a key protein kinase that regulates not only energy metabolism but also 
protein turnover in skeletal muscle. However, only a few recent studies have revealed the 
role of TRB3 in skeletal muscle (Koh et al., 2013; J. Liu et al., 2010; Zhang et al., 2013), 
and no study has focused on muscle protein turnover with TRB3 expression. Therefore, 
the overall purpose of this dissertation was to determine the role of TRB3 in skeletal 
muscle mass regulation and exercise-induced adaptation. To investigate this purpose, we 
first hypothesized that TRB3 expression would regulate protein synthesis and degradation 
by affecting Akt and its downstream proteins, mTOR and FOXO, in both basal states and 
atrophic conditions. We also hypothesized that TRB3 expression would influence 
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exercise-induced skeletal muscle adaptation in glucose uptake and mitochondrial 
biogenesis. The major findings from the experiments conducted in this dissertation 
demonstrates that (1) muscle-specific TRB3 overexpression decreases protein synthesis 
and increases protein degradation, while TRB3 knockout improves protein synthesis and 
reduces protein degradation, (2) under food-deprivation induced atrophic conditions, 
muscle-specific TRB3 overexpression worsens atrophy by accelerating protein 
degradation systems, whereas TRB3 knockout prevents atrophy by preserving the protein 
synthesis rate, and (3) muscle-specific TRB3 overexpression impairs exercise capacity 
and suppresses gene expressions related to glucose uptake and mitochondrial biogenesis, 
independent of training status, while TRB3 knockout improves glucose tolerance in both 
the absence and the presence of training. These findings provide preliminary insights into 
an important role that TRB3 might play in skeletal muscle plasticity. 
TRB3 regulates protein turnover through mTOR and FOXO at the basal status and 
under atrophic conditions 
Skeletal muscle mass is determined by the net dynamic balance between the rates 
of protein synthesis and protein degradation (Schiaffino et al., 2013; Schiaffino & 
Mammucari, 2011). TRB3 expression is mainly known as an inhibitor of Akt 
phosphorylation, an important cellular process not only in activating protein synthesis 
through phosphorylation of mTOR, but also in inactivating protein degradation through 
phosphorylation of FOXO (Blaauw et al., 2009; Schiaffino & Mammucari, 2011). 
Previously, hepatic and muscle-specific TRB3 overexpression has been shown to 
decrease insulin-stimulated Akt phosphorylation, resulting in impaired glucose tolerance 
and the development of insulin resistance (Du et al., 2003; Zhang et al., 2013). In Aim 1, 
we found that TG mice showed decreased hindlimb muscle weights compared to WT 
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littermates. This phenomenon could be due to suppressed phosphorylation of mTOR and 
S6K1 with decreased phosphorylation of FOXO in TG mice. In line with activated 
FOXO, atrogin-1 and MuRF-1 mRNA expression was greatly increased in TG mice with 
no changes to cathepsin L. However, we did not observe basal-level changes in Akt 
phosphorylation at either sites (T308 and S473) in TG mice. This could be due to our 
method, Western blot, which was perhaps not sufficient or not sensitive enough to detect 
the basal change in Akt phosphorylation. These results may suggest that other sensitive 
methods, including immunoprecipitation or Akt activity assay, are required to detect 
changes in Akt phosphorylation. In contrast to our results, a study from another group 
reveals that muscle-specific TRB3 overexpressed mice showed increased muscle mass 
and improved exercise capacity, along with more oxidative fibers (An et al., 2014). This 
discrepancy may be due to mouse background crossing, sex, and food differences; and/or 
to the distinct experimental settings. We have also demonstrated that TRB3 knockout 
increases muscle weights and protein synthesis rates, and that it decreases protein 
degradation. Although inconsistent data exists, our results are in line with our conclusion 
that TRB3 overexpression impairs the protein turnover needed to reduce muscle mass and 
function.  
In Aim 2, we observed that muscle-specific TRB3 overexpression worsened 48 hr 
food deprivation-induced atrophy, while TRB3 knockout protected loss of muscle mass 
in response to 48 hr food deprivation. Although TRB3 is known to be responsive to 
starvation in the liver (Du et al., 2003), we further demonstrated that food deprivation 
could increase TRB3 expression in skeletal muscle. We also reported that the detrimental 
effects of muscle-specific TRB3 overexpression on food deprivation-induced skeletal 
muscle atrophy could result from aggravated ubiquitin-proteasomal and autophagy-
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lysosomal proteolysis. Consistent with our previous finding, TG mice displayed 
significantly suppressed protein synthesis rates in fed state, but this finding was not 
further exacerbated by 48 hr food deprivation. On the other hand, TRB3 knockout did 
decrease the protein synthesis rates after 48 hr food deprivation, but KO mice preserved a 
higher protein synthesis rate than WT littermates. This could explain how KO mice 
ameliorated skeletal muscle atrophy under 48 hr food deprivation condition. Taken 
together, these findings strongly support the hypothesis that TRB3 is a major regulator of 
protein turnover in skeletal muscle at the basal level and under food deprivation-induced 
atrophic conditions.  
ER stress controls TRB3 expression in skeletal muscle in response to 48 hr food-
deprivation atrophic condition 
TRB3 is known to be responsive to various cellular stresses, including starvation 
and insulin resistance (Ord et al., 2007; Ord & Ord, 2003, 2005). Endoplasmic reticulum 
(ER) is an organelle responsible for protein synthesis in cells. Cellular stress increases 
burdens of protein synthesis in ER and can activates unfolded protein response (UPR) to 
manage protein synthesis. Uncontrolled UPR can induce ER stress, which can not only 
inhibit cell survival mechanisms but also facilitate apoptosis (Dicks et al., 2015; 
Guerrero-Hernandez et al., 2014; J. Wang et al., 2013). Previously, ER stress markers, 
such as ATF4 and CHOP, showed the possibility of regulating TRB3 expression in 
multiple cell lines (Ohoka et al., 2005; Ord et al., 2007; Ord & Ord, 2003, 2005). In 
addition, our lab has found that TRB3 expression mediates ER stress-induced insulin 
resistance in mouse skeletal muscle (Koh et al., 2013). However, no prior studies had 
investigated the means by which TRB3 expression was controlled in skeletal muscle 
under stressful conditions. Our second study provided an evidence that ER stress could be 
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an upstream regulator of TRB3 expression in skeletal muscle. When we measured ER 
stress markers in skeletal muscle, we observed that various ER stress markers, including 
XBP1 and ATF4, were greatly increased after 48 hr food deprivation. Furthermore, we 
treated C2C12 myotubes with 4-PBA, a chemical chaperon to block ER stress, in PBS for 
6 hr to mimic starvation. Intriguingly, we found that the blocking of ER stress completely 
abolished TRB3 expression and expression of muscle-specific ubiquitin ligases. 
Collectively, these data provide evidence that ER stress can be a regulator of TRB3 
expression in skeletal muscle and that TRB3 is possibly associated with regulating 
muscle-specific ubiquitin ligases under atrophic conditions. Future studies are required to 
determine the mechanism(s) by which ER stress regulates TRB3 expression and muscle-
specific ubiquitin ligases in skeletal muscle.  
TRB3 expression in healthy skeletal muscle influence exercise-induced adaptation in 
glucose tolerance and mitochondrial biogenesis  
Endurance exercise training induces skeletal muscle adaptations in both structure 
and function (Baar et al., 2002; J.O. Holloszy, Oscai, Mole, & Don, 1970; J.O. Holloszy, 
Rennie, Hickson, Conlee, & Hagberg, 1977). Established skeletal muscle adaptation is 
largely categorized into metabolic and structural adaptations (e.g., improved glucose 
uptake and increased mitochondrial biogenesis, respectively) (G.D. Cartee & Holloszy, 
1990; Hansen et al., 1998; J.O. Holloszy, 1988; J. O. Holloszy & Booth, 1976; J.O. 
Holloszy & Coyle, 1984; Ivy, Young, McLane, Fell, & Holloszy, 1983). Increased TRB3 
expression found in obese and diabetic rodent models is abolished after both acute and 
chronic endurance exercise (Lima et al., 2009; Marinho et al., 2012; Matos et al., 2010). 
This reduction in TRB3 expression results in decreased interaction between Akt and 
TRB3 and increased glucose uptake in the liver and skeletal muscle (Lima et al., 2009; 
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Marinho et al., 2012; Matos et al., 2010). However, no studies have investigated whether 
TRB3 expression in skeletal muscle affects exercise-induced skeletal adaptation at the 
basal conditions. In Aim 3, we observed that muscle-specific TRB3 overexpression 
impaired running capacity as measured by 6-week voluntary wheel exercise. Previously, 
another group tested the same TG mice for exercise capacity as assessed by time-to-
exhaustion, and they reported that muscle-specific TRB3 overexpression improved 
exercise capacity, along with containing more oxidative fibers (An et al., 2014). This 
variation could have multiple explanations, including a different number of backcrossing, 
food, sex, and age. Furthermore, we demonstrated that muscle-specific TRB3 
overexpression sstrongly suppressed the expressions of genes responsible for glucose 
uptake, such as GLUT4 and HXKII; and mitochondrial contents, including PGC1α, 
COX4, Cyt c, and CS. This could explain why muscle-specific TRB3 overexpression 
impaired glucose tolerance after 6-week treadmill running. Reduced HXKII expression in 
skeletal muscle has been associated with impaired glucose uptake and exercise capacity 
(Fueger et al., 2003; Fueger et al., 2005). Additionally, it has been demonstrated that 
PGC1α-deficient mice show decreased muscle glycogen and GLUT4 expression post-
exercise (Wende et al., 2007). Furthermore, PGC1α expression activates GLUT4 gene 
expression through myocyte enhance factor 2C (MEF2C) (Michael et al., 2001). 
Unfortunately, it is currently unknown whether muscle-specific TRB3 overexpression 
could be associated with MEF2C in regulating the expression of GLUT4 and PGC1α. 
Future studies are recommended to examine the mechanism(s) by which TRB3 
expression controls transcription of genes involved in exercise-induced skeletal muscle 
adaptation.  
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SUMMARY 
In summary, muscle-specific TRB3 overexpression decreased muscle mass while 
TRB3 knockout increased muscle weight at the basal state. Muscle-specific TRB3 
overexpression suppressed protein synthesis and promoted protein degradation via 
regulation of the Akt/mTOR/FOXO pathway. TRB3 knockout increased the protein 
synthesis rate in healthy skeletal muscle. Under 48 hr food deprivation, muscle-specific 
TRB3 overexpression worsened atrophy by stimulating proteolysis systems, whereas 
TRB3 knockout prevented atrophy by sustaining a higher protein synthesis rate. 
Furthermore, in C2C12 myotubes, food deprivation-induced ER stress could regulate 
TRB3 expression and muscle-specific ubiquitin E3 ligases. Lastly, muscle-specific TRB3 
overexpression impaired exercise capacity and suppressed the expressions of genes 
needed for glucose uptake and mitochondrial biogenesis, while TRB3 knockout improved 
glucose tolerance independent of training status without altering the expressions of genes 
responsible for glucose uptake or mitochondrial biogenesis. In conclusion, these data 
suggest that TRB3 plays a critical role in regulating skeletal muscle plasticity.  
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